id sid tid token lemma pos iajs-53 1 1 microsoft microsoft PROPN iajs-53 1 2 word word NOUN iajs-53 1 3 125 125 NUM iajs-53 1 4 - - SYM iajs-53 1 5 132 132 NUM iajs-53 1 6 125 125 NUM iajs-53 1 7 | | NOUN iajs-53 1 8 chemistry chemistry NOUN iajs-53 1 9 2016عام 2016عام NOUN iajs-53 1 10 ) ) PUNCT iajs-53 1 11 1(العدد 1(العدد NUM iajs-53 1 12 29المجلد 29المجلد PUNCT iajs-53 1 13 مجلة مجلة VERB iajs-53 1 14 إبن إبن VERB iajs-53 1 15 الهيثم الهيثم ADJ iajs-53 1 16 للعلوم للعلوم NOUN iajs-53 1 17 الصرفة الصرفة NOUN iajs-53 2 1 و و PRON iajs-53 2 2 التطبيقية التطبيقية ADJ iajs-53 2 3 ibn ibn PROPN iajs-53 2 4 al al PROPN iajs-53 2 5 - - PUNCT iajs-53 2 6 haitham haitham PROPN iajs-53 2 7 jour jour X iajs-53 2 8 . . PROPN iajs-53 2 9 for for ADP iajs-53 2 10 pure pure ADJ iajs-53 2 11 & & CCONJ iajs-53 2 12 appl appl PROPN iajs-53 2 13 . . PUNCT iajs-53 3 1 sci sci PROPN iajs-53 3 2 . . PUNCT iajs-53 3 3 vol vol NOUN iajs-53 3 4 . . PROPN iajs-53 3 5 29 29 NUM iajs-53 3 6 ( ( PUNCT iajs-53 3 7 1 1 NUM iajs-53 3 8 ) ) SYM iajs-53 3 9 2016 2016 NUM iajs-53 3 10 comparative comparative ADJ iajs-53 3 11 biochemical biochemical ADJ iajs-53 3 12 study study NOUN iajs-53 3 13 of of ADP iajs-53 3 14 insulin insulin NOUN iajs-53 3 15 like like ADP iajs-53 3 16 growth growth NOUN iajs-53 3 17 factor-1(igf-1 factor-1(igf-1 PROPN iajs-53 3 18 ) ) PUNCT iajs-53 3 19 in in ADP iajs-53 3 20 sera sera NOUN iajs-53 3 21 of of ADP iajs-53 3 22 controlled control VERB iajs-53 3 23 and and CCONJ iajs-53 3 24 uncontrolled uncontrolled ADJ iajs-53 3 25 dyslipidemia dyslipidemia NOUN iajs-53 3 26 in in ADP iajs-53 3 27 type2 type2 PROPN iajs-53 3 28 diabetic diabetic ADJ iajs-53 3 29 iraqi iraqi ADJ iajs-53 3 30 patients patient NOUN iajs-53 3 31 and and CCONJ iajs-53 3 32 healthy healthy ADJ iajs-53 3 33 control control NOUN iajs-53 3 34 . . PUNCT iajs-53 4 1 omar omar PROPN iajs-53 4 2 k. k. PROPN iajs-53 4 3 mahmmod mahmmod PROPN iajs-53 4 4 elham elham PROPN iajs-53 4 5 m. m. PROPN iajs-53 4 6 hussein hussein PROPN iajs-53 4 7 dept dept PROPN iajs-53 4 8 . . PROPN iajs-53 5 1 of of ADP iajs-53 5 2 chemistry chemistry NOUN iajs-53 5 3 / / SYM iajs-53 5 4 college college NOUN iajs-53 5 5 of of ADP iajs-53 5 6 education education NOUN iajs-53 5 7 for for ADP iajs-53 5 8 pure pure ADJ iajs-53 5 9 science science NOUN iajs-53 5 10 ( ( PUNCT iajs-53 5 11 ibn ibn PROPN iajs-53 5 12 al al PROPN iajs-53 5 13 - - PUNCT iajs-53 5 14 haitham haitham PROPN iajs-53 5 15 ) ) PUNCT iajs-53 5 16 university university PROPN iajs-53 5 17 of of ADP iajs-53 5 18 baghdad baghdad PROPN iajs-53 5 19 received receive VERB iajs-53 5 20 in in ADP iajs-53 5 21 : : PUNCT iajs-53 5 22 1 1 NUM iajs-53 5 23 / / SYM iajs-53 5 24 june/2015 june/2015 PROPN iajs-53 5 25 , , PUNCT iajs-53 5 26 accepted accept VERB iajs-53 5 27 in:30 in:30 PROPN iajs-53 5 28 / / SYM iajs-53 5 29 june/2015 june/2015 PROPN iajs-53 5 30 abstract abstract VERB iajs-53 5 31 the the DET iajs-53 5 32 objective objective NOUN iajs-53 5 33 of of ADP iajs-53 5 34 the the DET iajs-53 5 35 present present ADJ iajs-53 5 36 study study NOUN iajs-53 5 37 is be AUX iajs-53 5 38 to to PART iajs-53 5 39 compare compare VERB iajs-53 5 40 the the DET iajs-53 5 41 effect effect NOUN iajs-53 5 42 of of ADP iajs-53 5 43 insulin insulin NOUN iajs-53 5 44 like like ADP iajs-53 5 45 growth growth NOUN iajs-53 5 46 factor-1 factor-1 NUM iajs-53 5 47 on on ADP iajs-53 5 48 the the DET iajs-53 5 49 lipid lipid NOUN iajs-53 5 50 profile profile NOUN iajs-53 5 51 in in ADP iajs-53 5 52 sera sera NOUN iajs-53 5 53 of of ADP iajs-53 5 54 diabetic diabetic ADJ iajs-53 5 55 patients patient NOUN iajs-53 5 56 with with ADP iajs-53 5 57 and and CCONJ iajs-53 5 58 without without ADP iajs-53 5 59 dyslipidemia dyslipidemia NOUN iajs-53 5 60 having have VERB iajs-53 5 61 the the DET iajs-53 5 62 same same ADJ iajs-53 5 63 medical medical ADJ iajs-53 5 64 treatment treatment NOUN iajs-53 5 65 and and CCONJ iajs-53 5 66 compared compare VERB iajs-53 5 67 with with ADP iajs-53 5 68 healthy healthy ADJ iajs-53 5 69 control control NOUN iajs-53 5 70 . . PUNCT iajs-53 6 1 the the DET iajs-53 6 2 study study NOUN iajs-53 6 3 included include VERB iajs-53 6 4 three three NUM iajs-53 6 5 groups group NOUN iajs-53 6 6 . . PUNCT iajs-53 7 1 the the DET iajs-53 7 2 biochemical biochemical ADJ iajs-53 7 3 parameters parameter NOUN iajs-53 7 4 which which PRON iajs-53 7 5 were be AUX iajs-53 7 6 measured measure VERB iajs-53 7 7 include include NOUN iajs-53 7 8 , , PUNCT iajs-53 7 9 fasting fast VERB iajs-53 7 10 blood blood NOUN iajs-53 7 11 sugar(fbs sugar(fbs NOUN iajs-53 7 12 ) ) PUNCT iajs-53 7 13 , , PUNCT iajs-53 7 14 glycated glycate VERB iajs-53 7 15 hemoglobin hemoglobin NOUN iajs-53 7 16 ( ( PUNCT iajs-53 7 17 hba1c hba1c PROPN iajs-53 7 18 ) ) PUNCT iajs-53 7 19 , , PUNCT iajs-53 7 20 fasting fast VERB iajs-53 7 21 insulin insulin NOUN iajs-53 7 22 , , PUNCT iajs-53 7 23 insulin insulin NOUN iajs-53 7 24 like like ADP iajs-53 7 25 growth growth NOUN iajs-53 7 26 factor-1(igf-1 factor-1(igf-1 PROPN iajs-53 7 27 ) ) PUNCT iajs-53 7 28 , , PUNCT iajs-53 7 29 lipid lipid NOUN iajs-53 7 30 profile profile NOUN iajs-53 8 1 [ [ X iajs-53 8 2 total total ADJ iajs-53 8 3 cholesterol cholesterol NOUN iajs-53 8 4 ( ( PUNCT iajs-53 8 5 tc tc NOUN iajs-53 8 6 ) ) PUNCT iajs-53 8 7 , , PUNCT iajs-53 8 8 triglyceride(tg triglyceride(tg PROPN iajs-53 8 9 ) ) PUNCT iajs-53 8 10 , , PUNCT iajs-53 8 11 high high ADJ iajs-53 8 12 density density NOUN iajs-53 8 13 lipoprotein lipoprotein ADJ iajs-53 8 14 cholesterol(hdl cholesterol(hdl PROPN iajs-53 8 15 - - PUNCT iajs-53 8 16 c c NOUN iajs-53 8 17 ) ) PUNCT iajs-53 8 18 , , PUNCT iajs-53 8 19 low low ADJ iajs-53 8 20 density density NOUN iajs-53 8 21 lipoprotein lipoprotein NOUN iajs-53 8 22 - - PUNCT iajs-53 8 23 cholesterol cholesterol NOUN iajs-53 8 24 ( ( PUNCT iajs-53 8 25 ldl ldl NOUN iajs-53 8 26 - - PUNCT iajs-53 8 27 c)and c)and NOUN iajs-53 8 28 very very ADV iajs-53 8 29 low low ADJ iajs-53 8 30 density density NOUN iajs-53 8 31 lipoprotein lipoprotein ADJ iajs-53 8 32 - - PUNCT iajs-53 8 33 cholesterol cholesterol NOUN iajs-53 8 34 ( ( PUNCT iajs-53 8 35 vldl vldl NOUN iajs-53 8 36 - - PUNCT iajs-53 8 37 c c NOUN iajs-53 8 38 ) ) PUNCT iajs-53 8 39 ] ] X iajs-53 8 40 , , PUNCT iajs-53 8 41 atherogenic atherogenic ADJ iajs-53 8 42 index index NOUN iajs-53 8 43 of of ADP iajs-53 8 44 plasma(aip plasma(aip NOUN iajs-53 8 45 ) ) PUNCT iajs-53 8 46 , , PUNCT iajs-53 8 47 insulin insulin NOUN iajs-53 8 48 resistance(ir resistance(ir NOUN iajs-53 8 49 ) ) PUNCT iajs-53 8 50 . . PUNCT iajs-53 9 1 the the DET iajs-53 9 2 results result NOUN iajs-53 9 3 revealed reveal VERB iajs-53 9 4 a a DET iajs-53 9 5 significant significant ADJ iajs-53 9 6 increase increase NOUN iajs-53 9 7 in in ADP iajs-53 9 8 fbs fbs PROPN iajs-53 9 9 , , PUNCT iajs-53 9 10 hba1c hba1c PROPN iajs-53 9 11 , , PUNCT iajs-53 9 12 tc tc PRON iajs-53 9 13 , , PUNCT iajs-53 9 14 tg tg PRON iajs-53 9 15 , , PUNCT iajs-53 9 16 ldl ldl NOUN iajs-53 9 17 - - PUNCT iajs-53 9 18 c c PROPN iajs-53 9 19 , , PUNCT iajs-53 9 20 vldl vldl NOUN iajs-53 9 21 - - PUNCT iajs-53 9 22 c c PROPN iajs-53 9 23 , , PUNCT iajs-53 9 24 aip aip PROPN iajs-53 9 25 , , PUNCT iajs-53 9 26 insulin insulin NOUN iajs-53 9 27 level level NOUN iajs-53 9 28 and and CCONJ iajs-53 9 29 homa homa NOUN iajs-53 9 30 - - PUNCT iajs-53 9 31 ir ir PROPN iajs-53 9 32 while while SCONJ iajs-53 9 33 a a DET iajs-53 9 34 significant significant ADJ iajs-53 9 35 decrease decrease NOUN iajs-53 9 36 in in ADP iajs-53 9 37 igf-1 igf-1 NOUN iajs-53 9 38 and and CCONJ iajs-53 9 39 hdl hdl PROPN iajs-53 9 40 - - PUNCT iajs-53 9 41 c c PROPN iajs-53 9 42 in in ADP iajs-53 9 43 g2 g2 PROPN iajs-53 9 44 and and CCONJ iajs-53 9 45 g3 g3 PROPN iajs-53 9 46 was be AUX iajs-53 9 47 noticed notice VERB iajs-53 9 48 comparing compare VERB iajs-53 9 49 to to ADP iajs-53 9 50 g1 g1 VERB iajs-53 9 51 . . PUNCT iajs-53 10 1 the the DET iajs-53 10 2 conclusion conclusion NOUN iajs-53 10 3 could could AUX iajs-53 10 4 be be AUX iajs-53 10 5 drown drown VERB iajs-53 10 6 from from ADP iajs-53 10 7 the the DET iajs-53 10 8 present present ADJ iajs-53 10 9 study study NOUN iajs-53 10 10 that that SCONJ iajs-53 10 11 low low ADJ iajs-53 10 12 levels level NOUN iajs-53 10 13 of of ADP iajs-53 10 14 igf-1 igf-1 NOUN iajs-53 10 15 in in ADP iajs-53 10 16 groups group NOUN iajs-53 10 17 comparing compare VERB iajs-53 10 18 with with ADP iajs-53 10 19 healthy healthy ADJ iajs-53 10 20 control control NOUN iajs-53 10 21 , , PUNCT iajs-53 10 22 which which PRON iajs-53 10 23 may may AUX iajs-53 10 24 be be AUX iajs-53 10 25 led lead VERB iajs-53 10 26 to to ADP iajs-53 10 27 the the DET iajs-53 10 28 high high ADJ iajs-53 10 29 levels level NOUN iajs-53 10 30 of of ADP iajs-53 10 31 insulin insulin NOUN iajs-53 10 32 resistance resistance NOUN iajs-53 10 33 , , PUNCT iajs-53 10 34 while while SCONJ iajs-53 10 35 no no DET iajs-53 10 36 effect effect NOUN iajs-53 10 37 of of ADP iajs-53 10 38 dyslipidemia dyslipidemia NOUN iajs-53 10 39 on on ADP iajs-53 10 40 igf-1 igf-1 NOUN iajs-53 10 41 . . PUNCT iajs-53 11 1 key key ADJ iajs-53 11 2 words word NOUN iajs-53 11 3 : : PUNCT iajs-53 11 4 type2 type2 PROPN iajs-53 11 5 diabetes diabetes NOUN iajs-53 11 6 mellitus mellitus PROPN iajs-53 11 7 dm dm PROPN iajs-53 11 8 , , PUNCT iajs-53 11 9 igf-1 igf-1 PRON iajs-53 11 10 , , PUNCT iajs-53 11 11 ir ir INTJ iajs-53 11 12 . . PUNCT iajs-53 12 1 126 126 NUM iajs-53 12 2 | | ADV iajs-53 12 3 chemistry chemistry NOUN iajs-53 12 4 2016عام 2016عام NOUN iajs-53 12 5 ) ) PUNCT iajs-53 13 1 1(العدد 1(العدد NUM iajs-53 13 2 29لمجلد 29لمجلد NUM iajs-53 14 1 ا ا X iajs-53 15 1 مجلة مجلة ADJ iajs-53 15 2 إبن إبن VERB iajs-53 15 3 الهيثم الهيثم ADJ iajs-53 15 4 للعلوم للعلوم NOUN iajs-53 15 5 الصرفة الصرفة NOUN iajs-53 16 1 و و PRON iajs-53 16 2 التطبيقية التطبيقية ADJ iajs-53 16 3 ibn ibn PROPN iajs-53 16 4 al al PROPN iajs-53 16 5 - - PUNCT iajs-53 16 6 haitham haitham PROPN iajs-53 16 7 jour jour X iajs-53 16 8 . . PROPN iajs-53 16 9 for for ADP iajs-53 16 10 pure pure ADJ iajs-53 16 11 & & CCONJ iajs-53 16 12 appl appl PROPN iajs-53 16 13 . . PUNCT iajs-53 17 1 sci sci PROPN iajs-53 17 2 . . PUNCT iajs-53 17 3 vol vol NOUN iajs-53 17 4 . . PROPN iajs-53 17 5 29 29 NUM iajs-53 17 6 ( ( PUNCT iajs-53 17 7 1 1 NUM iajs-53 17 8 ) ) SYM iajs-53 17 9 2016 2016 NUM iajs-53 17 10 introduction introduction NOUN iajs-53 17 11 insulin insulin NOUN iajs-53 17 12 - - PUNCT iajs-53 17 13 like like ADJ iajs-53 17 14 growth growth NOUN iajs-53 17 15 factor-1(igf-1 factor-1(igf-1 PROPN iajs-53 17 16 ) ) PUNCT iajs-53 17 17 is be AUX iajs-53 17 18 a a DET iajs-53 17 19 small small ADJ iajs-53 17 20 polypeptide polypeptide NOUN iajs-53 17 21 ( ( PUNCT iajs-53 17 22 70 70 NUM iajs-53 17 23 amino amino NOUN iajs-53 17 24 acid acid NOUN iajs-53 17 25 & & CCONJ iajs-53 17 26 7500kda 7500kda NOUN iajs-53 17 27 ) ) PUNCT iajs-53 17 28 straight straight ADJ iajs-53 17 29 chain chain NOUN iajs-53 17 30 synthesized synthesize VERB iajs-53 17 31 mainly mainly ADV iajs-53 17 32 by by ADP iajs-53 17 33 the the DET iajs-53 17 34 liver liver NOUN iajs-53 17 35 in in ADP iajs-53 17 36 response response NOUN iajs-53 17 37 to to ADP iajs-53 17 38 growth growth NOUN iajs-53 17 39 hormone(gh)action[1 hormone(gh)action[1 PROPN iajs-53 17 40 ] ] X iajs-53 17 41 . . PUNCT iajs-53 18 1 it it PRON iajs-53 18 2 shares share VERB iajs-53 18 3 nearly nearly ADV iajs-53 18 4 50 50 NUM iajs-53 18 5 % % NOUN iajs-53 18 6 amino amino NOUN iajs-53 18 7 acid acid NOUN iajs-53 18 8 sequence sequence NOUN iajs-53 18 9 homology homology NOUN iajs-53 18 10 with with ADP iajs-53 18 11 proinsulin proinsulin PROPN iajs-53 18 12 , , PUNCT iajs-53 18 13 it it PRON iajs-53 18 14 composed compose VERB iajs-53 18 15 of of ADP iajs-53 18 16 an an DET iajs-53 18 17 alpha alpha NOUN iajs-53 18 18 and and CCONJ iajs-53 18 19 a a DET iajs-53 18 20 beta beta NOUN iajs-53 18 21 chain chain NOUN iajs-53 18 22 connected connect VERB iajs-53 18 23 by by ADP iajs-53 18 24 disulfide disulfide NOUN iajs-53 18 25 bonds[2 bonds[2 PROPN iajs-53 18 26 ] ] X iajs-53 18 27 . . PUNCT iajs-53 19 1 igf-1 igf-1 PRON iajs-53 19 2 is be AUX iajs-53 19 3 present present ADJ iajs-53 19 4 in in ADP iajs-53 19 5 circulation circulation NOUN iajs-53 19 6 in in ADP iajs-53 19 7 the the DET iajs-53 19 8 free free ADJ iajs-53 19 9 form form NOUN iajs-53 19 10 and and CCONJ iajs-53 19 11 in in ADP iajs-53 19 12 the the DET iajs-53 19 13 form form NOUN iajs-53 19 14 complexed complexe VERB iajs-53 19 15 with with ADP iajs-53 19 16 protein protein NOUN iajs-53 19 17 which which PRON iajs-53 19 18 bind bind VERB iajs-53 19 19 ( ( PUNCT iajs-53 19 20 igfbp igfbp PROPN iajs-53 19 21 ) ) PUNCT iajs-53 19 22 . . PUNCT iajs-53 20 1 six six NUM iajs-53 20 2 igf igf ADJ iajs-53 20 3 - - ADJ iajs-53 20 4 binding bind VERB iajs-53 20 5 proteins protein NOUN iajs-53 20 6 were be AUX iajs-53 20 7 identified identify VERB iajs-53 20 8 with with ADP iajs-53 20 9 various various ADJ iajs-53 20 10 affinity affinity NOUN iajs-53 20 11 to to ADP iajs-53 20 12 igf-1 igf-1 NOUN iajs-53 20 13 , , PUNCT iajs-53 20 14 main main ADJ iajs-53 20 15 binding bind VERB iajs-53 20 16 protein protein NOUN iajs-53 20 17 of of ADP iajs-53 20 18 igfs igfs NOUN iajs-53 20 19 is be AUX iajs-53 20 20 igfbp-3 igfbp-3 NUM iajs-53 20 21 and and CCONJ iajs-53 20 22 its its PRON iajs-53 20 23 synthesis synthesis NOUN iajs-53 20 24 is be AUX iajs-53 20 25 mainly mainly ADV iajs-53 20 26 determined determine VERB iajs-53 20 27 by by ADP iajs-53 20 28 growth growth NOUN iajs-53 20 29 hormone[3 hormone[3 NOUN iajs-53 20 30 ] ] X iajs-53 20 31 . . PUNCT iajs-53 21 1 igf-1 igf-1 NOUN iajs-53 21 2 synthesis synthesis NOUN iajs-53 21 3 remains remains AUX iajs-53 21 4 linked link VERB iajs-53 21 5 to to ADP iajs-53 21 6 nutrient nutrient NOUN iajs-53 21 7 intake intake NOUN iajs-53 21 8 and and CCONJ iajs-53 21 9 has have AUX iajs-53 21 10 retained retain VERB iajs-53 21 11 some some DET iajs-53 21 12 insulin insulin NOUN iajs-53 21 13 - - PUNCT iajs-53 21 14 like like ADJ iajs-53 21 15 properties property NOUN iajs-53 21 16 such such ADJ iajs-53 21 17 as as ADP iajs-53 21 18 stimulation stimulation NOUN iajs-53 21 19 of of ADP iajs-53 21 20 glucose glucose NOUN iajs-53 21 21 transport transport NOUN iajs-53 21 22 into into ADP iajs-53 21 23 skeletal skeletal ADJ iajs-53 21 24 muscle muscle NOUN iajs-53 21 25 cell[3 cell[3 PROPN iajs-53 21 26 ] ] PUNCT iajs-53 21 27 . . PUNCT iajs-53 22 1 decreased decrease VERB iajs-53 22 2 levels level NOUN iajs-53 22 3 of of ADP iajs-53 22 4 circulating circulate VERB iajs-53 22 5 igf-1 igf-1 NOUN iajs-53 22 6 in in ADP iajs-53 22 7 diabetic diabetic ADJ iajs-53 22 8 patients patient NOUN iajs-53 22 9 have have AUX iajs-53 22 10 been be AUX iajs-53 22 11 discovered discover VERB iajs-53 22 12 to to PART iajs-53 22 13 be be AUX iajs-53 22 14 associated associate VERB iajs-53 22 15 with with ADP iajs-53 22 16 insulin insulin NOUN iajs-53 22 17 resistance resistance NOUN iajs-53 22 18 [ [ X iajs-53 22 19 4],which 4],which PROPN iajs-53 22 20 is be AUX iajs-53 22 21 a a DET iajs-53 22 22 pathological pathological ADJ iajs-53 22 23 state state NOUN iajs-53 22 24 in in ADP iajs-53 22 25 which which PRON iajs-53 22 26 insulin insulin NOUN iajs-53 22 27 action action NOUN iajs-53 22 28 is be AUX iajs-53 22 29 impaired impair VERB iajs-53 22 30 in in ADP iajs-53 22 31 target target NOUN iajs-53 22 32 tissues tissue NOUN iajs-53 22 33 , , PUNCT iajs-53 22 34 including include VERB iajs-53 22 35 liver liver NOUN iajs-53 22 36 , , PUNCT iajs-53 22 37 skeletal skeletal ADJ iajs-53 22 38 muscle muscle NOUN iajs-53 22 39 and and CCONJ iajs-53 22 40 adipose adipose ADP iajs-53 22 41 tissue[5 tissue[5 PROPN iajs-53 22 42 ] ] PUNCT iajs-53 22 43 . . PUNCT iajs-53 23 1 igf-1 igf-1 NOUN iajs-53 23 2 levels level NOUN iajs-53 23 3 are be AUX iajs-53 23 4 strongly strongly ADV iajs-53 23 5 determined determine VERB iajs-53 23 6 by by ADP iajs-53 23 7 changes change NOUN iajs-53 23 8 in in ADP iajs-53 23 9 growth growth NOUN iajs-53 23 10 hormone hormone NOUN iajs-53 23 11 secretion[6 secretion[6 PROPN iajs-53 23 12 ] ] PUNCT iajs-53 23 13 . . PUNCT iajs-53 24 1 dyslipidemia dyslipidemia NOUN iajs-53 24 2 is be AUX iajs-53 24 3 increased increase VERB iajs-53 24 4 in in ADP iajs-53 24 5 the the DET iajs-53 24 6 lipid lipid NOUN iajs-53 24 7 and and CCONJ iajs-53 24 8 lipoprotein lipoprotein ADJ iajs-53 24 9 , , PUNCT iajs-53 24 10 it it PRON iajs-53 24 11 is be AUX iajs-53 24 12 elevated elevate VERB iajs-53 24 13 of of ADP iajs-53 24 14 plasma plasma NOUN iajs-53 24 15 cholesterol cholesterol NOUN iajs-53 24 16 ( ( PUNCT iajs-53 24 17 tc tc NOUN iajs-53 24 18 ) ) PUNCT iajs-53 24 19 , , PUNCT iajs-53 24 20 triglyceride triglyceride INTJ iajs-53 24 21 ( ( PUNCT iajs-53 24 22 tg tg INTJ iajs-53 24 23 ) ) PUNCT iajs-53 24 24 , , PUNCT iajs-53 24 25 or or CCONJ iajs-53 24 26 both both PRON iajs-53 24 27 , , PUNCT iajs-53 24 28 or or CCONJ iajs-53 24 29 a a DET iajs-53 24 30 low low ADJ iajs-53 24 31 hdl hdl PROPN iajs-53 24 32 - - PUNCT iajs-53 24 33 c c NOUN iajs-53 24 34 level level NOUN iajs-53 24 35 that that PRON iajs-53 24 36 contributes contribute VERB iajs-53 24 37 to to ADP iajs-53 24 38 the the DET iajs-53 24 39 development development NOUN iajs-53 24 40 of of ADP iajs-53 24 41 atherosclerosis atherosclerosis NOUN iajs-53 24 42 [ [ X iajs-53 24 43 7 7 NUM iajs-53 24 44 ] ] PUNCT iajs-53 24 45 . . PUNCT iajs-53 25 1 the the DET iajs-53 25 2 abnormal abnormal ADJ iajs-53 25 3 lipid lipid NOUN iajs-53 25 4 profile profile NOUN iajs-53 25 5 observed observe VERB iajs-53 25 6 in in ADP iajs-53 25 7 type2 type2 PROPN iajs-53 25 8 dm dm PROPN iajs-53 25 9 may may AUX iajs-53 25 10 be be AUX iajs-53 25 11 related relate VERB iajs-53 25 12 to to ADP iajs-53 25 13 insulin insulin NOUN iajs-53 25 14 resistance resistance NOUN iajs-53 25 15 which which PRON iajs-53 25 16 has have AUX iajs-53 25 17 been be AUX iajs-53 25 18 closely closely ADV iajs-53 25 19 associated associate VERB iajs-53 25 20 with with ADP iajs-53 25 21 diabetic diabetic ADJ iajs-53 25 22 dyslipidemia dyslipidemia NOUN iajs-53 25 23 and and CCONJ iajs-53 25 24 hypertension[8,9 hypertension[8,9 NUM iajs-53 25 25 ] ] PUNCT iajs-53 25 26 . . PUNCT iajs-53 26 1 aim aim NOUN iajs-53 26 2 of of ADP iajs-53 26 3 the the DET iajs-53 26 4 study study NOUN iajs-53 26 5 the the DET iajs-53 26 6 aim aim NOUN iajs-53 26 7 of of ADP iajs-53 26 8 this this DET iajs-53 26 9 study study NOUN iajs-53 26 10 is be AUX iajs-53 26 11 to to PART iajs-53 26 12 compare compare VERB iajs-53 26 13 the the DET iajs-53 26 14 effect effect NOUN iajs-53 26 15 of of ADP iajs-53 26 16 insulin insulin NOUN iajs-53 26 17 like like ADP iajs-53 26 18 growth growth NOUN iajs-53 26 19 factor-1 factor-1 NUM iajs-53 26 20 on on ADP iajs-53 26 21 the the DET iajs-53 26 22 lipid lipid NOUN iajs-53 26 23 profile profile NOUN iajs-53 26 24 in in ADP iajs-53 26 25 sera sera NOUN iajs-53 26 26 of of ADP iajs-53 26 27 iraqi iraqi ADJ iajs-53 26 28 diabetic diabetic ADJ iajs-53 26 29 patients patient NOUN iajs-53 26 30 with with ADP iajs-53 26 31 and and CCONJ iajs-53 26 32 without without ADP iajs-53 26 33 dyslipidemia dyslipidemia NOUN iajs-53 26 34 having have VERB iajs-53 26 35 the the DET iajs-53 26 36 same same ADJ iajs-53 26 37 medical medical ADJ iajs-53 26 38 treatment treatment NOUN iajs-53 26 39 and and CCONJ iajs-53 26 40 compared compare VERB iajs-53 26 41 with with ADP iajs-53 26 42 healthy healthy ADJ iajs-53 26 43 control control NOUN iajs-53 26 44 , , PUNCT iajs-53 26 45 this this PRON iajs-53 26 46 may may AUX iajs-53 26 47 provide provide VERB iajs-53 26 48 an an DET iajs-53 26 49 additional additional ADJ iajs-53 26 50 factor factor NOUN iajs-53 26 51 of of ADP iajs-53 26 52 glucose glucose NOUN iajs-53 26 53 homeostasis homeostasis NOUN iajs-53 26 54 . . PUNCT iajs-53 27 1 subjects subject NOUN iajs-53 27 2 and and CCONJ iajs-53 27 3 methods method NOUN iajs-53 27 4 the the DET iajs-53 27 5 studied study VERB iajs-53 27 6 groups group NOUN iajs-53 27 7 comprised comprise VERB iajs-53 27 8 of of ADP iajs-53 27 9 ( ( PUNCT iajs-53 27 10 20)subjects 20)subjects NUM iajs-53 27 11 [ [ X iajs-53 27 12 ( ( PUNCT iajs-53 27 13 10)male 10)male NUM iajs-53 27 14 and and CCONJ iajs-53 27 15 ( ( PUNCT iajs-53 27 16 10 10 NUM iajs-53 27 17 ) ) PUNCT iajs-53 27 18 female female NOUN iajs-53 27 19 ] ] PUNCT iajs-53 27 20 as as ADP iajs-53 27 21 healthy healthy ADJ iajs-53 27 22 control control NOUN iajs-53 27 23 group1(g1 group1(g1 NOUN iajs-53 27 24 ) ) PUNCT iajs-53 27 25 and and CCONJ iajs-53 27 26 g2 g2 NOUN iajs-53 27 27 which which PRON iajs-53 27 28 consist consist VERB iajs-53 27 29 of of ADP iajs-53 27 30 type2 type2 PROPN iajs-53 27 31 dm dm X iajs-53 27 32 with with ADP iajs-53 27 33 controlled control VERB iajs-53 27 34 lipidemia lipidemia NOUN iajs-53 28 1 [ [ X iajs-53 28 2 ( ( PUNCT iajs-53 28 3 11)male 11)male NUM iajs-53 28 4 and and CCONJ iajs-53 28 5 ( ( PUNCT iajs-53 28 6 9)female 9)female NUM iajs-53 28 7 ] ] PUNCT iajs-53 28 8 and and CCONJ iajs-53 28 9 g3 g3 NOUN iajs-53 28 10 which which PRON iajs-53 28 11 consist consist VERB iajs-53 28 12 of of ADP iajs-53 28 13 type2 type2 PROPN iajs-53 28 14 dm dm AUX iajs-53 28 15 patient patient NOUN iajs-53 28 16 with with ADP iajs-53 28 17 dyslipidemia dyslipidemia NOUN iajs-53 28 18 [ [ X iajs-53 28 19 ( ( PUNCT iajs-53 28 20 9 9 NUM iajs-53 28 21 ) ) PUNCT iajs-53 28 22 male male NOUN iajs-53 28 23 and and CCONJ iajs-53 28 24 ( ( PUNCT iajs-53 28 25 11 11 NUM iajs-53 28 26 ) ) PUNCT iajs-53 28 27 female female NOUN iajs-53 28 28 ] ] PUNCT iajs-53 28 29 . . PUNCT iajs-53 29 1 all all DET iajs-53 29 2 studied study VERB iajs-53 29 3 groups group NOUN iajs-53 29 4 matched match VERB iajs-53 29 5 with with ADP iajs-53 29 6 age age NOUN iajs-53 29 7 range range NOUN iajs-53 29 8 ( ( PUNCT iajs-53 29 9 45 45 NUM iajs-53 29 10 - - SYM iajs-53 29 11 65 65 NUM iajs-53 29 12 ) ) PUNCT iajs-53 29 13 years year NOUN iajs-53 29 14 and and CCONJ iajs-53 29 15 body body NOUN iajs-53 29 16 mass mass NOUN iajs-53 29 17 index index NOUN iajs-53 29 18 ( ( PUNCT iajs-53 29 19 bmi)(25 bmi)(25 PROPN iajs-53 29 20 - - PUNCT iajs-53 29 21 29 29 NUM iajs-53 29 22 kg kg NOUN iajs-53 29 23 / / SYM iajs-53 29 24 m2 m2 PROPN iajs-53 29 25 ) ) PUNCT iajs-53 29 26 . . PUNCT iajs-53 30 1 smokers smoker NOUN iajs-53 30 2 , , PUNCT iajs-53 30 3 alcoholics alcoholic NOUN iajs-53 30 4 and and CCONJ iajs-53 30 5 patient patient ADJ iajs-53 30 6 with with ADP iajs-53 30 7 cardiovascular cardiovascular ADJ iajs-53 30 8 disease disease NOUN iajs-53 30 9 , , PUNCT iajs-53 30 10 insulin insulin NOUN iajs-53 30 11 treatment treatment NOUN iajs-53 30 12 , , PUNCT iajs-53 30 13 kidney kidney NOUN iajs-53 30 14 disease disease NOUN iajs-53 30 15 , , PUNCT iajs-53 30 16 hepatic hepatic ADJ iajs-53 30 17 failure failure NOUN iajs-53 30 18 and and CCONJ iajs-53 30 19 statins statin NOUN iajs-53 30 20 treatment treatment NOUN iajs-53 30 21 were be AUX iajs-53 30 22 excluded exclude VERB iajs-53 30 23 . . PUNCT iajs-53 31 1 blood blood NOUN iajs-53 31 2 samples sample NOUN iajs-53 31 3 were be AUX iajs-53 31 4 collected collect VERB iajs-53 31 5 from from ADP iajs-53 31 6 venipuncture venipuncture NOUN iajs-53 31 7 each each DET iajs-53 31 8 subject subject NOUN iajs-53 31 9 in in ADP iajs-53 31 10 the the DET iajs-53 31 11 study study NOUN iajs-53 31 12 after after ADP iajs-53 31 13 12 12 NUM iajs-53 31 14 hours hour NOUN iajs-53 31 15 fasting fast VERB iajs-53 31 16 . . PUNCT iajs-53 32 1 samples sample NOUN iajs-53 32 2 were be AUX iajs-53 32 3 immediately immediately ADV iajs-53 32 4 centrifuge centrifuge ADJ iajs-53 32 5 and and CCONJ iajs-53 32 6 serum serum NOUN iajs-53 32 7 was be AUX iajs-53 32 8 separated separate VERB iajs-53 32 9 and and CCONJ iajs-53 32 10 frozen freeze VERB iajs-53 32 11 until until ADP iajs-53 32 12 assayed assayed ADJ iajs-53 32 13 , , PUNCT iajs-53 32 14 for for ADP iajs-53 32 15 determination determination NOUN iajs-53 32 16 of of ADP iajs-53 32 17 fasting fast VERB iajs-53 32 18 serum serum NOUN iajs-53 32 19 glucose glucose NOUN iajs-53 33 1 [ [ X iajs-53 33 2 10 10 NUM iajs-53 33 3 ] ] PUNCT iajs-53 33 4 . . PUNCT iajs-53 34 1 total total ADJ iajs-53 34 2 cholesterol[11 cholesterol[11 PROPN iajs-53 34 3 ] ] X iajs-53 34 4 , , PUNCT iajs-53 34 5 high high ADJ iajs-53 34 6 density density NOUN iajs-53 34 7 lipoprotein lipoprotein ADJ iajs-53 34 8 cholesterol cholesterol NOUN iajs-53 34 9 hdl hdl PROPN iajs-53 34 10 - - PUNCT iajs-53 34 11 c[12 c[12 PROPN iajs-53 34 12 ] ] PUNCT iajs-53 34 13 and and CCONJ iajs-53 34 14 triglyceride triglyceride INTJ iajs-53 34 15 tg tg X iajs-53 35 1 [ [ X iajs-53 35 2 13 13 NUM iajs-53 35 3 ] ] PUNCT iajs-53 35 4 were be AUX iajs-53 35 5 determined determine VERB iajs-53 35 6 by by ADP iajs-53 35 7 using use VERB iajs-53 35 8 commercial commercial ADJ iajs-53 35 9 kits kit NOUN iajs-53 35 10 ( ( PUNCT iajs-53 35 11 bio bio PROPN iajs-53 35 12 labo labo PROPN iajs-53 35 13 sa sa PROPN iajs-53 35 14 - - PUNCT iajs-53 35 15 france france PROPN iajs-53 35 16 ) ) PUNCT iajs-53 35 17 . . PUNCT iajs-53 36 1 ldl ldl NOUN iajs-53 36 2 - - PUNCT iajs-53 36 3 c c PROPN iajs-53 36 4 and and CCONJ iajs-53 36 5 vldl vldl PROPN iajs-53 36 6 - - PUNCT iajs-53 36 7 c c PROPN iajs-53 36 8 were be AUX iajs-53 36 9 calculated calculate VERB iajs-53 36 10 by by ADP iajs-53 36 11 freidweld freidweld ADJ iajs-53 36 12 equation[14 equation[14 PROPN iajs-53 36 13 ] ] PUNCT iajs-53 36 14 . . PUNCT iajs-53 37 1 ldl ldl NOUN iajs-53 37 2 - - PUNCT iajs-53 37 3 c c NOUN iajs-53 37 4 = = NOUN iajs-53 37 5 total total ADJ iajs-53 37 6 cholesterol-(hdl cholesterol-(hdl ADJ iajs-53 37 7 - - PUNCT iajs-53 37 8 c+vldl c+vldl NOUN iajs-53 37 9 - - PUNCT iajs-53 37 10 c c NOUN iajs-53 37 11 ) ) PUNCT iajs-53 37 12 vldl vldl NOUN iajs-53 37 13 - - PUNCT iajs-53 37 14 c(mg c(mg NOUN iajs-53 37 15 / / SYM iajs-53 37 16 dl)=(tg(mg dl)=(tg(mg NOUN iajs-53 37 17 / / SYM iajs-53 37 18 dl/5 dl/5 PROPN iajs-53 37 19 ) ) PUNCT iajs-53 37 20 fasting fast VERB iajs-53 37 21 serum serum NOUN iajs-53 37 22 insulin insulin NOUN iajs-53 37 23 [ [ X iajs-53 37 24 15 15 NUM iajs-53 37 25 ] ] PUNCT iajs-53 37 26 was be AUX iajs-53 37 27 determined determine VERB iajs-53 37 28 by by ADP iajs-53 37 29 using use VERB iajs-53 37 30 elisa elisa NOUN iajs-53 37 31 kit kit NOUN iajs-53 37 32 ( ( PUNCT iajs-53 37 33 drg drg NOUN iajs-53 37 34 - - PUNCT iajs-53 37 35 germany germany NOUN iajs-53 37 36 ) ) PUNCT iajs-53 37 37 . . PUNCT iajs-53 38 1 insulin insulin NOUN iajs-53 38 2 like like ADP iajs-53 38 3 growth growth NOUN iajs-53 38 4 factor-1 factor-1 PROPN iajs-53 38 5 ( ( PUNCT iajs-53 38 6 igf-1 igf-1 NOUN iajs-53 38 7 ) ) PUNCT iajs-53 38 8 was be AUX iajs-53 38 9 determined determine VERB iajs-53 38 10 by by ADP iajs-53 38 11 radioimmunoassay radioimmunoassay NOUN iajs-53 38 12 using use VERB iajs-53 38 13 commercial commercial ADJ iajs-53 38 14 kits kit NOUN iajs-53 38 15 ( ( PUNCT iajs-53 38 16 beckman beckman PROPN iajs-53 38 17 coulter coulter PROPN iajs-53 38 18 ) ) PUNCT iajs-53 38 19 -germany -germany PROPN iajs-53 38 20 . . PUNCT iajs-53 39 1 the the DET iajs-53 39 2 bound bind VERB iajs-53 39 3 radioactivity radioactivity NOUN iajs-53 39 4 is be AUX iajs-53 39 5 directly directly ADV iajs-53 39 6 proportional proportional ADJ iajs-53 39 7 to to ADP iajs-53 39 8 igf-1 igf-1 NOUN iajs-53 39 9 concentration concentration NOUN iajs-53 39 10 in in ADP iajs-53 39 11 the the DET iajs-53 39 12 sample sample NOUN iajs-53 39 13 ( ( PUNCT iajs-53 39 14 immunotech immunotech NOUN iajs-53 39 15 s.r.o s.r.o NOUN iajs-53 39 16 – – PUNCT iajs-53 39 17 radiova radiova PROPN iajs-53 39 18 , , PUNCT iajs-53 39 19 i i PRON iajs-53 39 20 ) ) PUNCT iajs-53 39 21 . . PUNCT iajs-53 40 1 insulin insulin NOUN iajs-53 40 2 resistance resistance NOUN iajs-53 40 3 was be AUX iajs-53 40 4 assayed assay VERB iajs-53 40 5 by by ADP iajs-53 40 6 calculating calculate VERB iajs-53 40 7 the the DET iajs-53 40 8 homeostasis homeostasis NOUN iajs-53 40 9 model model NOUN iajs-53 40 10 assessment assessment NOUN iajs-53 40 11 for for ADP iajs-53 40 12 insulin insulin NOUN iajs-53 40 13 resistance resistance NOUN iajs-53 40 14 ( ( PUNCT iajs-53 40 15 homa homa NOUN iajs-53 40 16 - - PUNCT iajs-53 40 17 ir ir NOUN iajs-53 40 18 ) ) PUNCT iajs-53 40 19 which which PRON iajs-53 40 20 is be AUX iajs-53 40 21 estimated estimate VERB iajs-53 40 22 using use VERB iajs-53 40 23 the the DET iajs-53 40 24 following follow VERB iajs-53 40 25 formula formula NOUN iajs-53 40 26 . . PUNCT iajs-53 41 1 homa homa NOUN iajs-53 41 2 - - PUNCT iajs-53 41 3 ir= ir= PROPN iajs-53 42 1 [ [ X iajs-53 42 2 ( ( PUNCT iajs-53 42 3 fasting fast VERB iajs-53 42 4 glucose glucose NOUN iajs-53 42 5 x x SYM iajs-53 42 6 fasting fast VERB iajs-53 42 7 insulin)/405 insulin)/405 NOUN iajs-53 42 8 ] ] PUNCT iajs-53 43 1 [ [ X iajs-53 43 2 16 16 NUM iajs-53 43 3 ] ] PUNCT iajs-53 43 4 . . PUNCT iajs-53 44 1 127 127 NUM iajs-53 44 2 | | ADV iajs-53 44 3 chemistry chemistry NOUN iajs-53 44 4 2016عام 2016عام NOUN iajs-53 44 5 ) ) PUNCT iajs-53 45 1 1(العدد 1(العدد NUM iajs-53 45 2 29لمجلد 29لمجلد NUM iajs-53 46 1 ا ا X iajs-53 47 1 مجلة مجلة ADJ iajs-53 47 2 إبن إبن VERB iajs-53 47 3 الهيثم الهيثم ADJ iajs-53 47 4 للعلوم للعلوم NOUN iajs-53 47 5 الصرفة الصرفة NOUN iajs-53 48 1 و و PRON iajs-53 48 2 التطبيقية التطبيقية ADJ iajs-53 48 3 ibn ibn PROPN iajs-53 48 4 al al PROPN iajs-53 48 5 - - PUNCT iajs-53 48 6 haitham haitham PROPN iajs-53 48 7 jour jour X iajs-53 48 8 . . PROPN iajs-53 48 9 for for ADP iajs-53 48 10 pure pure ADJ iajs-53 48 11 & & CCONJ iajs-53 48 12 appl appl PROPN iajs-53 48 13 . . PUNCT iajs-53 49 1 sci sci PROPN iajs-53 49 2 . . PUNCT iajs-53 49 3 vol vol NOUN iajs-53 49 4 . . PROPN iajs-53 49 5 29 29 NUM iajs-53 49 6 ( ( PUNCT iajs-53 49 7 1 1 NUM iajs-53 49 8 ) ) SYM iajs-53 49 9 2016 2016 NUM iajs-53 49 10 atherogenic atherogenic ADJ iajs-53 49 11 index index NOUN iajs-53 49 12 of of ADP iajs-53 49 13 plasma plasma NOUN iajs-53 49 14 ( ( PUNCT iajs-53 49 15 aip aip PROPN iajs-53 49 16 ) ) PUNCT iajs-53 49 17 calculated calculate VERB iajs-53 49 18 from from ADP iajs-53 49 19 the the DET iajs-53 49 20 formula formula NOUN iajs-53 49 21 ( ( PUNCT iajs-53 49 22 aip aip PROPN iajs-53 49 23 = = PROPN iajs-53 49 24 log(tg log(tg PROPN iajs-53 49 25 / / SYM iajs-53 49 26 hdl hdl PROPN iajs-53 49 27 - - PUNCT iajs-53 49 28 c c NOUN iajs-53 49 29 ) ) PUNCT iajs-53 49 30 ) ) PUNCT iajs-53 50 1 [ [ X iajs-53 50 2 17 17 NUM iajs-53 50 3 ] ] PUNCT iajs-53 50 4 . . PUNCT iajs-53 51 1 the the DET iajs-53 51 2 results result NOUN iajs-53 51 3 were be AUX iajs-53 51 4 expressed express VERB iajs-53 51 5 as as SCONJ iajs-53 51 6 mean mean PROPN iajs-53 51 7 ± ± NUM iajs-53 51 8 sem sem NOUN iajs-53 51 9 and and CCONJ iajs-53 51 10 p≥0.05 p≥0.05 NOUN iajs-53 51 11 was be AUX iajs-53 51 12 considered consider VERB iajs-53 51 13 significant significant ADJ iajs-53 51 14 . . PUNCT iajs-53 52 1 unpaired unpaired ADJ iajs-53 52 2 student student NOUN iajs-53 52 3 t t PROPN iajs-53 52 4 - - PUNCT iajs-53 52 5 test test NOUN iajs-53 52 6 was be AUX iajs-53 52 7 used use VERB iajs-53 52 8 to to PART iajs-53 52 9 examine examine VERB iajs-53 52 10 the the DET iajs-53 52 11 differences difference NOUN iajs-53 52 12 of of ADP iajs-53 52 13 mean mean ADJ iajs-53 52 14 . . PUNCT iajs-53 53 1 results result NOUN iajs-53 53 2 and and CCONJ iajs-53 53 3 discussion discussion NOUN iajs-53 53 4 table(1 table(1 PROPN iajs-53 53 5 ) ) PUNCT iajs-53 53 6 showed show VERB iajs-53 53 7 a a DET iajs-53 53 8 significant significant ADJ iajs-53 53 9 increase increase NOUN iajs-53 53 10 in in ADP iajs-53 53 11 fasting fast VERB iajs-53 53 12 blood blood NOUN iajs-53 53 13 sugar sugar NOUN iajs-53 53 14 ( ( PUNCT iajs-53 53 15 fbs)in fbs)in VERB iajs-53 53 16 both both CCONJ iajs-53 53 17 diabetic diabetic ADJ iajs-53 53 18 groups group NOUN iajs-53 53 19 , , PUNCT iajs-53 53 20 g2(167.45± g2(167.45± PROPN iajs-53 53 21 7.66 7.66 NUM iajs-53 53 22 mg mg PROPN iajs-53 53 23 / / SYM iajs-53 53 24 dl)and dl)and NOUN iajs-53 53 25 g3(201.75±15.14 g3(201.75±15.14 NUM iajs-53 53 26 mg mg PROPN iajs-53 53 27 / / SYM iajs-53 53 28 dl dl NOUN iajs-53 53 29 ) ) PUNCT iajs-53 53 30 compared compare VERB iajs-53 53 31 to to ADP iajs-53 53 32 control control NOUN iajs-53 53 33 group group NOUN iajs-53 53 34 ( ( PUNCT iajs-53 53 35 86.5±2.06 86.5±2.06 NUM iajs-53 53 36 mg mg PROPN iajs-53 53 37 / / SYM iajs-53 53 38 dl dl PROPN iajs-53 53 39 ) ) PUNCT iajs-53 53 40 , , PUNCT iajs-53 53 41 no no DET iajs-53 53 42 significant significant ADJ iajs-53 53 43 elevation elevation NOUN iajs-53 53 44 between between ADP iajs-53 53 45 g2 g2 PROPN iajs-53 53 46 and and CCONJ iajs-53 53 47 g3 g3 PROPN iajs-53 53 48 was be AUX iajs-53 53 49 observed observe VERB iajs-53 53 50 . . PUNCT iajs-53 54 1 patients patient NOUN iajs-53 54 2 with with ADP iajs-53 54 3 type2 type2 PROPN iajs-53 54 4 dm dm AUX iajs-53 54 5 characterized characterize VERB iajs-53 54 6 by by ADP iajs-53 54 7 insufficient insufficient ADJ iajs-53 54 8 secretion secretion NOUN iajs-53 54 9 of of ADP iajs-53 54 10 insulin insulin NOUN iajs-53 54 11 as as ADP iajs-53 54 12 a a DET iajs-53 54 13 defect defect NOUN iajs-53 54 14 of of ADP iajs-53 54 15 islet islet NOUN iajs-53 54 16 cell cell NOUN iajs-53 54 17 function function NOUN iajs-53 54 18 or or CCONJ iajs-53 54 19 β β NOUN iajs-53 54 20 - - NOUN iajs-53 54 21 cell cell NOUN iajs-53 54 22 mass mass NOUN iajs-53 54 23 which which PRON iajs-53 54 24 cause cause VERB iajs-53 54 25 an an DET iajs-53 54 26 increase increase NOUN iajs-53 54 27 in in ADP iajs-53 54 28 blood blood NOUN iajs-53 54 29 sugar[18 sugar[18 NOUN iajs-53 54 30 ] ] PUNCT iajs-53 54 31 . . PUNCT iajs-53 55 1 glycated glycate VERB iajs-53 55 2 hemoglobin hemoglobin NOUN iajs-53 55 3 ( ( PUNCT iajs-53 55 4 hba1c hba1c PROPN iajs-53 55 5 ) ) PUNCT iajs-53 55 6 showed show VERB iajs-53 55 7 a a DET iajs-53 55 8 significant significant ADJ iajs-53 55 9 increase increase NOUN iajs-53 55 10 in in ADP iajs-53 55 11 both both CCONJ iajs-53 55 12 diabetic diabetic ADJ iajs-53 55 13 groups group NOUN iajs-53 55 14 , , PUNCT iajs-53 55 15 g2 g2 PROPN iajs-53 55 16 ( ( PUNCT iajs-53 55 17 7.84±0.22 7.84±0.22 NUM iajs-53 55 18 % % NOUN iajs-53 55 19 ) ) PUNCT iajs-53 55 20 and and CCONJ iajs-53 55 21 g3 g3 PROPN iajs-53 55 22 ( ( PUNCT iajs-53 55 23 8.40±0.42 8.40±0.42 NUM iajs-53 55 24 % % NOUN iajs-53 55 25 ) ) PUNCT iajs-53 55 26 compared compare VERB iajs-53 55 27 with with ADP iajs-53 55 28 g1 g1 PROPN iajs-53 55 29 ( ( PUNCT iajs-53 55 30 5.74±0.09 5.74±0.09 NUM iajs-53 55 31 % % NOUN iajs-53 55 32 ) ) PUNCT iajs-53 55 33 . . PUNCT iajs-53 56 1 a a DET iajs-53 56 2 significant significant ADJ iajs-53 56 3 correlation correlation NOUN iajs-53 56 4 was be AUX iajs-53 56 5 found find VERB iajs-53 56 6 between between ADP iajs-53 56 7 g1 g1 NOUN iajs-53 56 8 comparing compare VERB iajs-53 56 9 to to ADP iajs-53 56 10 g2 g2 PROPN iajs-53 56 11 and and CCONJ iajs-53 56 12 g3 g3 PROPN iajs-53 56 13 , , PUNCT iajs-53 56 14 while while SCONJ iajs-53 56 15 no no DET iajs-53 56 16 significant significant ADJ iajs-53 56 17 correlation correlation NOUN iajs-53 56 18 between between ADP iajs-53 56 19 two two NUM iajs-53 56 20 diabetic diabetic ADJ iajs-53 56 21 groups group NOUN iajs-53 56 22 was be AUX iajs-53 56 23 found find VERB iajs-53 56 24 . . PUNCT iajs-53 57 1 it it PRON iajs-53 57 2 has have AUX iajs-53 57 3 been be AUX iajs-53 57 4 reported report VERB iajs-53 57 5 that that SCONJ iajs-53 57 6 the the DET iajs-53 57 7 prevalence prevalence NOUN iajs-53 57 8 and and CCONJ iajs-53 57 9 overlap overlap NOUN iajs-53 57 10 between between ADP iajs-53 57 11 intermediate intermediate ADJ iajs-53 57 12 hyperglycemia hyperglycemia NOUN iajs-53 57 13 was be AUX iajs-53 57 14 defined define VERB iajs-53 57 15 by by ADP iajs-53 57 16 hba1c(5.7 hba1c(5.7 PROPN iajs-53 57 17 - - PUNCT iajs-53 57 18 6.4 6.4 NUM iajs-53 57 19 % % NOUN iajs-53 57 20 ) ) PUNCT iajs-53 57 21 , , PUNCT iajs-53 57 22 this this DET iajs-53 57 23 range range NOUN iajs-53 57 24 was be AUX iajs-53 57 25 proposed propose VERB iajs-53 57 26 as as ADP iajs-53 57 27 an an DET iajs-53 57 28 indicator indicator NOUN iajs-53 57 29 of of ADP iajs-53 57 30 type2 type2 PROPN iajs-53 57 31 dm dm PROPN iajs-53 57 32 . . NOUN iajs-53 57 33 table table NOUN iajs-53 57 34 ( ( PUNCT iajs-53 57 35 2 2 X iajs-53 57 36 ) ) PUNCT iajs-53 57 37 showed show VERB iajs-53 57 38 the the DET iajs-53 57 39 levels level NOUN iajs-53 57 40 of of ADP iajs-53 57 41 lipid lipid NOUN iajs-53 57 42 profile profile NOUN iajs-53 57 43 and and CCONJ iajs-53 57 44 aip aip PROPN iajs-53 57 45 in in ADP iajs-53 57 46 all all DET iajs-53 57 47 studied studied ADJ iajs-53 57 48 groups group NOUN iajs-53 57 49 . . PUNCT iajs-53 58 1 no no DET iajs-53 58 2 significant significant ADJ iajs-53 58 3 elevation elevation NOUN iajs-53 58 4 was be AUX iajs-53 58 5 found find VERB iajs-53 58 6 in in ADP iajs-53 58 7 tc tc NOUN iajs-53 58 8 , , PUNCT iajs-53 58 9 tg tg PRON iajs-53 58 10 , , PUNCT iajs-53 58 11 ldl ldl NOUN iajs-53 58 12 - - PUNCT iajs-53 58 13 c c PROPN iajs-53 58 14 , , PUNCT iajs-53 58 15 vldl vldl NOUN iajs-53 58 16 - - PUNCT iajs-53 58 17 c c PROPN iajs-53 58 18 and and CCONJ iajs-53 58 19 aip aip PROPN iajs-53 58 20 in in ADP iajs-53 58 21 g2 g2 PROPN iajs-53 58 22 comparing compare VERB iajs-53 58 23 to to PART iajs-53 58 24 g1 g1 VERB iajs-53 58 25 which which PRON iajs-53 58 26 tc(169.25±6.47mg tc(169.25±6.47mg NOUN iajs-53 58 27 / / SYM iajs-53 58 28 dl)comparing dl)comparing NOUN iajs-53 58 29 to to ADP iajs-53 58 30 g1(168.75±4.12mg g1(168.75±4.12mg NOUN iajs-53 58 31 / / SYM iajs-53 58 32 dl dl NOUN iajs-53 58 33 ) ) PUNCT iajs-53 58 34 and and CCONJ iajs-53 58 35 tg(138.85±3.11mg tg(138.85±3.11mg PROPN iajs-53 58 36 / / SYM iajs-53 58 37 dl dl NOUN iajs-53 58 38 ) ) PUNCT iajs-53 58 39 comparing compare VERB iajs-53 58 40 to to ADP iajs-53 58 41 g1(127.3±3.59mg g1(127.3±3.59mg PROPN iajs-53 58 42 / / SYM iajs-53 58 43 dl dl NOUN iajs-53 58 44 ) ) PUNCT iajs-53 58 45 , , PUNCT iajs-53 58 46 ldl ldl NOUN iajs-53 58 47 - - PUNCT iajs-53 58 48 c c PROPN iajs-53 58 49 ( ( PUNCT iajs-53 58 50 89.85±6.31mg 89.85±6.31mg PROPN iajs-53 58 51 / / SYM iajs-53 58 52 dl dl NOUN iajs-53 58 53 ) ) PUNCT iajs-53 58 54 comparing compare VERB iajs-53 58 55 to to ADP iajs-53 58 56 g1(88.75 g1(88.75 ADJ iajs-53 58 57     SPACE iajs-53 58 58 ±3.92mg ±3.92mg PROPN iajs-53 58 59 / / SYM iajs-53 58 60 dl dl NOUN iajs-53 58 61 ) ) PUNCT iajs-53 58 62 , , PUNCT iajs-53 58 63 vldl vldl NOUN iajs-53 58 64 - - PUNCT iajs-53 58 65 c(27.77±0.91mg c(27.77±0.91mg PROPN iajs-53 58 66 / / SYM iajs-53 58 67 dl dl NOUN iajs-53 58 68 ) ) PUNCT iajs-53 58 69 comparing compare VERB iajs-53 58 70 to to ADP iajs-53 58 71 g1(26.15±1.21mg g1(26.15±1.21mg PROPN iajs-53 58 72 / / SYM iajs-53 58 73 dl dl PROPN iajs-53 58 74 ) ) PUNCT iajs-53 58 75 and and CCONJ iajs-53 58 76 aip aip PROPN iajs-53 58 77 ( ( PUNCT iajs-53 58 78 0.45 0.45 NUM iajs-53 58 79     SPACE iajs-53 58 80 ±0.02 ±0.02 NOUN iajs-53 58 81 ) ) PUNCT iajs-53 58 82 comparing compare VERB iajs-53 58 83 to to ADP iajs-53 58 84 g1(0.36±0.02 g1(0.36±0.02 NOUN iajs-53 58 85 ) ) PUNCT iajs-53 58 86 . . PUNCT iajs-53 59 1 the the DET iajs-53 59 2 results result NOUN iajs-53 59 3 also also ADV iajs-53 59 4 revealed reveal VERB iajs-53 59 5 significant significant ADJ iajs-53 59 6 reduction reduction NOUN iajs-53 59 7 in in ADP iajs-53 59 8 hdl hdl PROPN iajs-53 59 9 - - PUNCT iajs-53 59 10 c c PROPN iajs-53 59 11 levels level NOUN iajs-53 59 12 in in ADP iajs-53 59 13 g2(44.95±1.61mg g2(44.95±1.61mg PROPN iajs-53 59 14 / / SYM iajs-53 59 15 dl dl PROPN iajs-53 59 16 ) ) PUNCT iajs-53 59 17 comparing compare VERB iajs-53 59 18 to to ADP iajs-53 59 19 g1(54.65±1.08mg g1(54.65±1.08mg PROPN iajs-53 59 20 / / SYM iajs-53 59 21 dl dl PROPN iajs-53 59 22 ) ) PUNCT iajs-53 59 23 . . PUNCT iajs-53 60 1 a a DET iajs-53 60 2 significant significant ADJ iajs-53 60 3 increase increase NOUN iajs-53 60 4 in in ADP iajs-53 60 5 tc tc NOUN iajs-53 60 6 , , PUNCT iajs-53 60 7 tg tg PRON iajs-53 60 8 , , PUNCT iajs-53 60 9 ldl ldl NOUN iajs-53 60 10 - - PUNCT iajs-53 60 11 c c PROPN iajs-53 60 12 , , PUNCT iajs-53 60 13 vldl vldl NOUN iajs-53 60 14 - - PUNCT iajs-53 60 15 c c PROPN iajs-53 60 16 and and CCONJ iajs-53 60 17 aip aip PROPN iajs-53 60 18 in in ADP iajs-53 60 19 g3 g3 PROPN iajs-53 60 20 was be AUX iajs-53 60 21 found find VERB iajs-53 60 22 comparing compare VERB iajs-53 60 23 to to ADP iajs-53 60 24 g2 g2 PROPN iajs-53 60 25 and and CCONJ iajs-53 60 26 g1 g1 NOUN iajs-53 60 27 which which PRON iajs-53 60 28 tc tc NOUN iajs-53 60 29 was be AUX iajs-53 60 30 ( ( PUNCT iajs-53 60 31 192.7±12.35mg 192.7±12.35mg NUM iajs-53 60 32 / / SYM iajs-53 60 33 dl dl NOUN iajs-53 60 34 ) ) PUNCT iajs-53 60 35 , , PUNCT iajs-53 60 36 tg tg PROPN iajs-53 60 37 was be AUX iajs-53 60 38 ( ( PUNCT iajs-53 60 39 186.75±16.44 186.75±16.44 NUM iajs-53 60 40 mg mg PROPN iajs-53 60 41 / / SYM iajs-53 60 42 dl dl PROPN iajs-53 60 43 ) ) PUNCT iajs-53 60 44 , , PUNCT iajs-53 60 45 ldl ldl PROPN iajs-53 60 46 - - PUNCT iajs-53 60 47 c c PROPN iajs-53 60 48 was be AUX iajs-53 60 49 ( ( PUNCT iajs-53 60 50 113.45±13.77mg 113.45±13.77mg NUM iajs-53 60 51 / / SYM iajs-53 60 52 dl dl NOUN iajs-53 60 53 ) ) PUNCT iajs-53 60 54 , , PUNCT iajs-53 60 55 vldl vldl NOUN iajs-53 60 56 - - PUNCT iajs-53 60 57 c c PROPN iajs-53 60 58 ( ( PUNCT iajs-53 60 59 36.9±3.32 36.9±3.32 NUM iajs-53 60 60 mg mg PROPN iajs-53 60 61 / / SYM iajs-53 60 62 dl dl PROPN iajs-53 60 63 ) ) PUNCT iajs-53 60 64 and and CCONJ iajs-53 60 65 aip aip PROPN iajs-53 60 66 was be AUX iajs-53 60 67 ( ( PUNCT iajs-53 60 68 0.60±0.04 0.60±0.04 NOUN iajs-53 60 69 ) ) PUNCT iajs-53 60 70 . . PUNCT iajs-53 61 1 a a DET iajs-53 61 2 significant significant ADJ iajs-53 61 3 reduction reduction NOUN iajs-53 61 4 in in ADP iajs-53 61 5 hdl hdl PROPN iajs-53 61 6 - - PUNCT iajs-53 61 7 c c PROPN iajs-53 61 8 was be AUX iajs-53 61 9 noticed notice VERB iajs-53 61 10 in in ADP iajs-53 61 11 g3 g3 PROPN iajs-53 61 12 ( ( PUNCT iajs-53 61 13 44.1±1.80)comparing 44.1±1.80)comparing NUM iajs-53 61 14 to to ADP iajs-53 61 15 g1 g1 NOUN iajs-53 61 16 , , PUNCT iajs-53 61 17 while while SCONJ iajs-53 61 18 no no DET iajs-53 61 19 significant significant ADJ iajs-53 61 20 reduction reduction NOUN iajs-53 61 21 was be AUX iajs-53 61 22 found find VERB iajs-53 61 23 between between ADP iajs-53 61 24 g2 g2 PROPN iajs-53 61 25 and and CCONJ iajs-53 61 26 g3 g3 PROPN iajs-53 61 27 . . PUNCT iajs-53 62 1 the the DET iajs-53 62 2 data datum NOUN iajs-53 62 3 in in ADP iajs-53 62 4 present present ADJ iajs-53 62 5 study study NOUN iajs-53 62 6 showed show VERB iajs-53 62 7 that that SCONJ iajs-53 62 8 dyslipidamic dyslipidamic ADJ iajs-53 62 9 subject subject NOUN iajs-53 62 10 had have VERB iajs-53 62 11 two two NUM iajs-53 62 12 lipid lipid ADJ iajs-53 62 13 values value NOUN iajs-53 62 14 outside outside ADP iajs-53 62 15 the the DET iajs-53 62 16 normal normal ADJ iajs-53 62 17 range range NOUN iajs-53 62 18 of of ADP iajs-53 62 19 which which PRON iajs-53 62 20 the the DET iajs-53 62 21 most most ADV iajs-53 62 22 frequent frequent ADJ iajs-53 62 23 combination combination NOUN iajs-53 62 24 was be AUX iajs-53 62 25 low low ADJ iajs-53 62 26 hdl hdl PROPN iajs-53 62 27 - - PUNCT iajs-53 62 28 c c PROPN iajs-53 62 29 and and CCONJ iajs-53 62 30 high high ADJ iajs-53 62 31 ldl ldl NOUN iajs-53 62 32 - - PUNCT iajs-53 62 33 c c NOUN iajs-53 62 34 which which PRON iajs-53 62 35 is be AUX iajs-53 62 36 in in ADP iajs-53 62 37 agreement agreement NOUN iajs-53 62 38 with with ADP iajs-53 62 39 cook cook NOUN iajs-53 62 40 et.al et.al ADJ iajs-53 62 41 study[19 study[19 NOUN iajs-53 62 42 ] ] PUNCT iajs-53 62 43 who who PRON iajs-53 62 44 observed observe VERB iajs-53 62 45 that that SCONJ iajs-53 62 46 54 54 NUM iajs-53 62 47 % % NOUN iajs-53 62 48 of of ADP iajs-53 62 49 dm dm PROPN iajs-53 62 50 subjects subject NOUN iajs-53 62 51 had have VERB iajs-53 62 52 two two NUM iajs-53 62 53 lipid lipid NOUN iajs-53 62 54 values value NOUN iajs-53 62 55 reduced reduce VERB iajs-53 62 56 hdl hdl PROPN iajs-53 62 57 - - PUNCT iajs-53 62 58 c c PROPN iajs-53 62 59 and and CCONJ iajs-53 62 60 increased increase VERB iajs-53 62 61 ldl ldl NOUN iajs-53 62 62 - - PUNCT iajs-53 62 63 c c PROPN iajs-53 62 64 as as ADP iajs-53 62 65 the the DET iajs-53 62 66 most most ADV iajs-53 62 67 frequent frequent ADJ iajs-53 62 68 combination combination NOUN iajs-53 62 69 outside outside ADP iajs-53 62 70 the the DET iajs-53 62 71 normal normal ADJ iajs-53 62 72 range range NOUN iajs-53 62 73 . . PUNCT iajs-53 63 1 the the DET iajs-53 63 2 most most ADV iajs-53 63 3 lipid lipid ADJ iajs-53 63 4 abnormality abnormality NOUN iajs-53 63 5 in in ADP iajs-53 63 6 our our PRON iajs-53 63 7 study study NOUN iajs-53 63 8 reduced reduce VERB iajs-53 63 9 hdl hdl PROPN iajs-53 63 10 - - PUNCT iajs-53 63 11 c c PROPN iajs-53 63 12 which which PRON iajs-53 63 13 is be AUX iajs-53 63 14 in in ADP iajs-53 63 15 agreement agreement NOUN iajs-53 63 16 with with ADP iajs-53 63 17 okafo okafo ADJ iajs-53 63 18 et.al et.al PROPN iajs-53 63 19 study[20 study[20 PROPN iajs-53 63 20 ] ] PUNCT iajs-53 63 21 . . PUNCT iajs-53 64 1 previous previous ADJ iajs-53 64 2 study study NOUN iajs-53 64 3 revealed reveal VERB iajs-53 64 4 that that SCONJ iajs-53 64 5 insulin insulin NOUN iajs-53 64 6 resistance resistance NOUN iajs-53 64 7 may may AUX iajs-53 64 8 be be AUX iajs-53 64 9 responsible responsible ADJ iajs-53 64 10 for for ADP iajs-53 64 11 low low ADJ iajs-53 64 12 hdl hdl PROPN iajs-53 64 13 - - PUNCT iajs-53 64 14 c c PROPN iajs-53 64 15 in in ADP iajs-53 64 16 patient patient NOUN iajs-53 64 17 with with ADP iajs-53 64 18 type2 type2 PROPN iajs-53 64 19 dm[21 dm[21 PROPN iajs-53 64 20 ] ] PUNCT iajs-53 64 21 . . PUNCT iajs-53 65 1 the the DET iajs-53 65 2 production production NOUN iajs-53 65 3 of of ADP iajs-53 65 4 hdl hdl PROPN iajs-53 65 5 - - PUNCT iajs-53 65 6 c c NOUN iajs-53 65 7 decreases decrease VERB iajs-53 65 8 due due ADP iajs-53 65 9 to to ADP iajs-53 65 10 the the DET iajs-53 65 11 alteration alteration NOUN iajs-53 65 12 in in ADP iajs-53 65 13 hepatic hepatic ADJ iajs-53 65 14 function function NOUN iajs-53 65 15 and and CCONJ iajs-53 65 16 increased increase VERB iajs-53 65 17 activity activity NOUN iajs-53 65 18 of of ADP iajs-53 65 19 hepatic hepatic ADJ iajs-53 65 20 lipase lipase NOUN iajs-53 65 21 which which PRON iajs-53 65 22 facilitates facilitate VERB iajs-53 65 23 hdl hdl PROPN iajs-53 65 24 - - PUNCT iajs-53 65 25 c c PROPN iajs-53 65 26 clearance clearance NOUN iajs-53 65 27 . . PUNCT iajs-53 66 1 dyslipidemia dyslipidemia NOUN iajs-53 66 2 is be AUX iajs-53 66 3 elevation elevation NOUN iajs-53 66 4 of of ADP iajs-53 66 5 plasma plasma NOUN iajs-53 66 6 cholesterol cholesterol NOUN iajs-53 66 7 , , PUNCT iajs-53 66 8 triglycerides triglyceride NOUN iajs-53 66 9 , , PUNCT iajs-53 66 10 or or CCONJ iajs-53 66 11 both both PRON iajs-53 66 12 or or CCONJ iajs-53 66 13 a a DET iajs-53 66 14 low low ADJ iajs-53 66 15 hdl hdl NOUN iajs-53 66 16 - - PUNCT iajs-53 66 17 c c PROPN iajs-53 66 18 , , PUNCT iajs-53 66 19 that that PRON iajs-53 66 20 contributes contribute VERB iajs-53 66 21 to to ADP iajs-53 66 22 the the DET iajs-53 66 23 development development NOUN iajs-53 66 24 of of ADP iajs-53 66 25 atherosclerosis atherosclerosis NOUN iajs-53 66 26 [ [ X iajs-53 66 27 22 22 NUM iajs-53 66 28 ] ] PUNCT iajs-53 66 29 . . PUNCT iajs-53 67 1 our our PRON iajs-53 67 2 study study NOUN iajs-53 67 3 revealed reveal VERB iajs-53 67 4 that that SCONJ iajs-53 67 5 there there PRON iajs-53 67 6 is be VERB iajs-53 67 7 a a DET iajs-53 67 8 slightly slightly ADJ iajs-53 67 9 increase increase NOUN iajs-53 67 10 in in ADP iajs-53 67 11 aip aip PROPN iajs-53 67 12 in in ADP iajs-53 67 13 g2 g2 PROPN iajs-53 67 14 who who PRON iajs-53 67 15 controlled control VERB iajs-53 67 16 their their PRON iajs-53 67 17 lipidemia lipidemia NOUN iajs-53 67 18 and and CCONJ iajs-53 67 19 high high ADJ iajs-53 67 20 increase increase NOUN iajs-53 67 21 of of ADP iajs-53 67 22 aip aip PROPN iajs-53 67 23 in in ADP iajs-53 67 24 g3 g3 PROPN iajs-53 67 25 with with ADP iajs-53 67 26 dyslipidemia dyslipidemia NOUN iajs-53 67 27 comparing compare VERB iajs-53 67 28 with with ADP iajs-53 67 29 control control NOUN iajs-53 67 30 ( ( PUNCT iajs-53 67 31 0.45±0.02)(0.6±0.04)respectively 0.45±0.02)(0.6±0.04)respectively ADV iajs-53 67 32 comparing compare VERB iajs-53 67 33 with with ADP iajs-53 67 34 ( ( PUNCT iajs-53 67 35 0.36±0.01 0.36±0.01 PROPN iajs-53 67 36 ) ) PUNCT iajs-53 67 37 , , PUNCT iajs-53 67 38 which which PRON iajs-53 67 39 is be AUX iajs-53 67 40 in in ADP iajs-53 67 41 agreement agreement NOUN iajs-53 67 42 with with ADP iajs-53 67 43 hermans hermans PROPN iajs-53 67 44 et.al et.al PROPN iajs-53 67 45 study[23 study[23 NOUN iajs-53 67 46 ] ] PUNCT iajs-53 67 47 . . PUNCT iajs-53 68 1 the the DET iajs-53 68 2 highest high ADJ iajs-53 68 3 value value NOUN iajs-53 68 4 of of ADP iajs-53 68 5 aip aip PROPN iajs-53 68 6 increased increase VERB iajs-53 68 7 significantly significantly ADV iajs-53 68 8 with with ADP iajs-53 68 9 increased increase VERB iajs-53 68 10 atherogenic atherogenic ADJ iajs-53 68 11 risk risk NOUN iajs-53 68 12 ( ( PUNCT iajs-53 68 13 0.2 0.2 NUM iajs-53 68 14 - - PUNCT iajs-53 68 15 0.5)and 0.5)and NOUN iajs-53 68 16 in in ADP iajs-53 68 17 patients patient NOUN iajs-53 68 18 with with ADP iajs-53 68 19 diabetes diabetes NOUN iajs-53 68 20 aip aip PROPN iajs-53 68 21 value value NOUN iajs-53 68 22 was be AUX iajs-53 68 23 among among ADP iajs-53 68 24 the the DET iajs-53 68 25 highest high ADJ iajs-53 68 26 level[24 level[24 NOUN iajs-53 68 27 ] ] PUNCT iajs-53 68 28 , , PUNCT iajs-53 68 29 therefore therefore ADV iajs-53 68 30 , , PUNCT iajs-53 68 31 aip aip PROPN iajs-53 68 32 is be AUX iajs-53 68 33 considered consider VERB iajs-53 68 34 a a DET iajs-53 68 35 higher high ADJ iajs-53 68 36 predicted predict VERB iajs-53 68 37 value value NOUN iajs-53 68 38 for for ADP iajs-53 68 39 atherosclerosis[25 atherosclerosis[25 NOUN iajs-53 68 40 ] ] PUNCT iajs-53 68 41 . . PUNCT iajs-53 69 1 a a DET iajs-53 69 2 study study NOUN iajs-53 69 3 data datum NOUN iajs-53 69 4 of of ADP iajs-53 69 5 aip aip PROPN iajs-53 69 6 value value NOUN iajs-53 69 7 revealed reveal VERB iajs-53 69 8 the the DET iajs-53 69 9 increasing increasing NOUN iajs-53 69 10 of of ADP iajs-53 69 11 aip aip PROPN iajs-53 69 12 value value NOUN iajs-53 69 13 proportion proportion NOUN iajs-53 69 14 to to ADP iajs-53 69 15 the the DET iajs-53 69 16 cardiovascular cardiovascular ADJ iajs-53 69 17 ( ( PUNCT iajs-53 69 18 cv cv ADJ iajs-53 69 19 ) ) PUNCT iajs-53 69 20 risk risk NOUN iajs-53 69 21 , , PUNCT iajs-53 69 22 this this DET iajs-53 69 23 value value NOUN iajs-53 69 24 increased increase VERB iajs-53 69 25 up up ADP iajs-53 69 26 to to ADP iajs-53 69 27 ( ( PUNCT iajs-53 69 28 0.4 0.4 NUM iajs-53 69 29 ) ) PUNCT iajs-53 69 30 , , PUNCT iajs-53 69 31 the the DET iajs-53 69 32 data datum NOUN iajs-53 69 33 showed show VERB iajs-53 69 34 the the DET iajs-53 69 35 aip aip PROPN iajs-53 69 36 ( ( PUNCT iajs-53 69 37 0.1 0.1 NUM iajs-53 69 38 - - PUNCT iajs-53 69 39 0.24 0.24 NUM iajs-53 69 40 ) ) PUNCT iajs-53 69 41 with with ADP iajs-53 69 42 medium medium ADJ iajs-53 69 43 risk risk NOUN iajs-53 69 44 and and CCONJ iajs-53 69 45 above above ADV iajs-53 69 46 ( ( PUNCT iajs-53 69 47 0.24)with 0.24)with NUM iajs-53 69 48 high high ADJ iajs-53 69 49 cv cv PROPN iajs-53 69 50 risk risk NOUN iajs-53 69 51 [ [ X iajs-53 69 52 26 26 NUM iajs-53 69 53 ] ] PUNCT iajs-53 69 54 . . PUNCT iajs-53 70 1 results result NOUN iajs-53 70 2 in in ADP iajs-53 70 3 table table NOUN iajs-53 70 4 ( ( PUNCT iajs-53 70 5 3 3 X iajs-53 70 6 ) ) PUNCT iajs-53 70 7 indicate indicate VERB iajs-53 70 8 that that SCONJ iajs-53 70 9 serum serum NOUN iajs-53 70 10 levels level NOUN iajs-53 70 11 of of ADP iajs-53 70 12 igf-1(ng igf-1(ng NOUN iajs-53 70 13 / / SYM iajs-53 70 14 ml ml NOUN iajs-53 70 15 ) ) PUNCT iajs-53 70 16 in in ADP iajs-53 70 17 g2&g3 g2&g3 PROPN iajs-53 70 18 ( ( PUNCT iajs-53 70 19 104±6.77ng 104±6.77ng NUM iajs-53 70 20 / / SYM iajs-53 70 21 ml ml NOUN iajs-53 70 22 ) ) PUNCT iajs-53 70 23 , , PUNCT iajs-53 70 24 ( ( PUNCT iajs-53 70 25 116.9±9.19ng 116.9±9.19ng NOUN iajs-53 70 26 / / SYM iajs-53 70 27 ml ml NOUN iajs-53 70 28 ) ) PUNCT iajs-53 70 29 respectively respectively ADV iajs-53 70 30 were be AUX iajs-53 70 31 significantly significantly ADV iajs-53 70 32 decreased decrease VERB iajs-53 70 33 , , PUNCT iajs-53 70 34 compared compare VERB iajs-53 70 35 with with ADP iajs-53 70 36 g1 g1 PROPN iajs-53 70 37 ( ( PUNCT iajs-53 70 38 236.45 236.45 NUM iajs-53 70 39     SPACE iajs-53 70 40 ±8.93 ±8.93 PROPN iajs-53 70 41 ng ng PROPN iajs-53 70 42 / / SYM iajs-53 70 43 ml ml PROPN iajs-53 70 44 ) ) PUNCT iajs-53 70 45 . . PUNCT iajs-53 71 1 128 128 NUM iajs-53 72 1 | | ADV iajs-53 72 2 chemistry chemistry NOUN iajs-53 72 3 2016عام 2016عام NOUN iajs-53 72 4 ) ) PUNCT iajs-53 73 1 1(العدد 1(العدد NUM iajs-53 73 2 29لمجلد 29لمجلد NUM iajs-53 74 1 ا ا X iajs-53 75 1 مجلة مجلة ADJ iajs-53 75 2 إبن إبن VERB iajs-53 75 3 الهيثم الهيثم ADJ iajs-53 75 4 للعلوم للعلوم NOUN iajs-53 75 5 الصرفة الصرفة NOUN iajs-53 76 1 و و PRON iajs-53 76 2 التطبيقية التطبيقية ADJ iajs-53 76 3 ibn ibn PROPN iajs-53 76 4 al al PROPN iajs-53 76 5 - - PUNCT iajs-53 76 6 haitham haitham PROPN iajs-53 76 7 jour jour X iajs-53 76 8 . . PROPN iajs-53 76 9 for for ADP iajs-53 76 10 pure pure ADJ iajs-53 76 11 & & CCONJ iajs-53 76 12 appl appl PROPN iajs-53 76 13 . . PUNCT iajs-53 77 1 sci sci PROPN iajs-53 77 2 . . PUNCT iajs-53 77 3 vol vol NOUN iajs-53 77 4 . . PROPN iajs-53 77 5 29 29 NUM iajs-53 77 6 ( ( PUNCT iajs-53 77 7 1 1 NUM iajs-53 77 8 ) ) SYM iajs-53 77 9 2016 2016 NUM iajs-53 77 10 serum serum NOUN iajs-53 77 11 igf-1 igf-1 NOUN iajs-53 77 12 levels level NOUN iajs-53 77 13 in in ADP iajs-53 77 14 patients patient NOUN iajs-53 77 15 with with ADP iajs-53 77 16 type2 type2 PROPN iajs-53 77 17 diabetes diabetes NOUN iajs-53 77 18 depend depend VERB iajs-53 77 19 on on ADP iajs-53 77 20 the the DET iajs-53 77 21 degree degree NOUN iajs-53 77 22 of of ADP iajs-53 77 23 metabolic metabolic NOUN iajs-53 77 24 control control NOUN iajs-53 77 25 , , PUNCT iajs-53 77 26 with with ADP iajs-53 77 27 near near ADP iajs-53 77 28 normal normal ADJ iajs-53 77 29 igf-1 igf-1 NOUN iajs-53 77 30 levels level NOUN iajs-53 77 31 in in ADP iajs-53 77 32 well well ADV iajs-53 77 33 controlled control VERB iajs-53 77 34 diabetics diabetic NOUN iajs-53 77 35 and and CCONJ iajs-53 77 36 decreased decrease VERB iajs-53 77 37 in in ADP iajs-53 77 38 poorly poorly ADV iajs-53 77 39 controlled control VERB iajs-53 77 40 diabetics diabetic NOUN iajs-53 77 41 , , PUNCT iajs-53 77 42 it it PRON iajs-53 77 43 has have AUX iajs-53 77 44 been be AUX iajs-53 77 45 suggested suggest VERB iajs-53 77 46 that that SCONJ iajs-53 77 47 lowered lower VERB iajs-53 77 48 serum serum NOUN iajs-53 77 49 igf-1 igf-1 NOUN iajs-53 77 50 concentration concentration NOUN iajs-53 77 51 predict predict VERB iajs-53 77 52 worsening worsen VERB iajs-53 77 53 of of ADP iajs-53 77 54 insulin insulin NOUN iajs-53 77 55 - - PUNCT iajs-53 77 56 mediated mediate VERB iajs-53 77 57 glucose glucose NOUN iajs-53 77 58 uptake uptake NOUN iajs-53 77 59 in in ADP iajs-53 77 60 older old ADJ iajs-53 77 61 people[27].conti people[27].conti PROPN iajs-53 77 62 et.al[28 et.al[28 PROPN iajs-53 77 63 ] ] PUNCT iajs-53 77 64 reported report VERB iajs-53 77 65 that that SCONJ iajs-53 77 66 insulin insulin NOUN iajs-53 77 67 has have VERB iajs-53 77 68 a a DET iajs-53 77 69 profound profound ADJ iajs-53 77 70 influence influence NOUN iajs-53 77 71 on on ADP iajs-53 77 72 the the DET iajs-53 77 73 igf-1 igf-1 NOUN iajs-53 77 74 axis axis NOUN iajs-53 77 75 and and CCONJ iajs-53 77 76 variation variation NOUN iajs-53 77 77 circulating circulate VERB iajs-53 77 78 insulin insulin NOUN iajs-53 77 79 concentration concentration NOUN iajs-53 77 80 is be AUX iajs-53 77 81 an an DET iajs-53 77 82 important important ADJ iajs-53 77 83 determination determination NOUN iajs-53 77 84 of of ADP iajs-53 77 85 igf-1 igf-1 NOUN iajs-53 77 86 bioactivity bioactivity NOUN iajs-53 77 87 , , PUNCT iajs-53 77 88 that that PRON iajs-53 77 89 means mean VERB iajs-53 77 90 the the DET iajs-53 77 91 fasting fasting NOUN iajs-53 77 92 decreases decrease VERB iajs-53 77 93 insulin insulin NOUN iajs-53 77 94 levels level NOUN iajs-53 77 95 which which PRON iajs-53 77 96 then then ADV iajs-53 77 97 reduces reduce VERB iajs-53 77 98 the the DET iajs-53 77 99 concentration concentration NOUN iajs-53 77 100 of of ADP iajs-53 77 101 growth growth NOUN iajs-53 77 102 hormone hormone NOUN iajs-53 77 103 ( ( PUNCT iajs-53 77 104 gh)receptors gh)receptor NOUN iajs-53 77 105 in in ADP iajs-53 77 106 hepatocytes hepatocyte NOUN iajs-53 77 107 which which PRON iajs-53 77 108 in in ADP iajs-53 77 109 turn turn NOUN iajs-53 77 110 causes cause VERB iajs-53 77 111 a a DET iajs-53 77 112 reduction reduction NOUN iajs-53 77 113 in in ADP iajs-53 77 114 igf-1 igf-1 NOUN iajs-53 77 115 . . PUNCT iajs-53 78 1 hasan hasan PROPN iajs-53 78 2 et.al[29 et.al[29 PROPN iajs-53 78 3 ] ] PUNCT iajs-53 78 4 indicated indicate VERB iajs-53 78 5 that that SCONJ iajs-53 78 6 igf-1 igf-1 PRON iajs-53 78 7 can can AUX iajs-53 78 8 be be AUX iajs-53 78 9 useful useful ADJ iajs-53 78 10 marker marker NOUN iajs-53 78 11 in in ADP iajs-53 78 12 the the DET iajs-53 78 13 insulin insulin NOUN iajs-53 78 14 resistance resistance NOUN iajs-53 78 15 because because SCONJ iajs-53 78 16 low low ADJ iajs-53 78 17 igf-1 igf-1 NOUN iajs-53 78 18 level level NOUN iajs-53 78 19 can can AUX iajs-53 78 20 help help VERB iajs-53 78 21 as as ADP iajs-53 78 22 a a DET iajs-53 78 23 better well ADJ iajs-53 78 24 identification identification NOUN iajs-53 78 25 of of ADP iajs-53 78 26 subject subject NOUN iajs-53 78 27 at at ADP iajs-53 78 28 risk risk NOUN iajs-53 78 29 type type NOUN iajs-53 78 30 diabetes diabetes NOUN iajs-53 78 31 and and CCONJ iajs-53 78 32 cardiovascular cardiovascular ADJ iajs-53 78 33 disease disease NOUN iajs-53 78 34 . . PUNCT iajs-53 79 1 the the DET iajs-53 79 2 data datum NOUN iajs-53 79 3 in in ADP iajs-53 79 4 table table NOUN iajs-53 79 5 ( ( PUNCT iajs-53 79 6 3 3 X iajs-53 79 7 ) ) PUNCT iajs-53 79 8 showed show VERB iajs-53 79 9 a a DET iajs-53 79 10 significant significant ADJ iajs-53 79 11 reduction reduction NOUN iajs-53 79 12 of of ADP iajs-53 79 13 igf-1 igf-1 NOUN iajs-53 79 14 in in ADP iajs-53 79 15 g2 g2 PROPN iajs-53 79 16 and and CCONJ iajs-53 79 17 g3 g3 PROPN iajs-53 79 18 comparing compare VERB iajs-53 79 19 to to AUX iajs-53 79 20 g1 g1 VERB iajs-53 79 21 . . PUNCT iajs-53 80 1 no no DET iajs-53 80 2 significant significant ADJ iajs-53 80 3 reduction reduction NOUN iajs-53 80 4 was be AUX iajs-53 80 5 observed observe VERB iajs-53 80 6 between between ADP iajs-53 80 7 two two NUM iajs-53 80 8 diabetics diabetic NOUN iajs-53 80 9 groups group NOUN iajs-53 80 10 g2&g3 g2&g3 PROPN iajs-53 80 11 . . PUNCT iajs-53 81 1 also also ADV iajs-53 81 2 the the DET iajs-53 81 3 results result NOUN iajs-53 81 4 presented present VERB iajs-53 81 5 in in ADP iajs-53 81 6 table-3 table-3 NUM iajs-53 81 7 indicated indicate VERB iajs-53 81 8 that that SCONJ iajs-53 81 9 fasting fast VERB iajs-53 81 10 insulin insulin NOUN iajs-53 81 11 and and CCONJ iajs-53 81 12 homa homa PROPN iajs-53 81 13 - - PUNCT iajs-53 81 14 ir ir PROPN iajs-53 81 15 values value NOUN iajs-53 81 16 were be AUX iajs-53 81 17 significantly significantly ADV iajs-53 81 18 higher high ADJ iajs-53 81 19 in in ADP iajs-53 81 20 g2&g3 g2&g3 PROPN iajs-53 81 21 than than ADP iajs-53 81 22 healthy healthy ADJ iajs-53 81 23 control control NOUN iajs-53 81 24 subjects subject NOUN iajs-53 81 25 . . PUNCT iajs-53 82 1 insulin insulin NOUN iajs-53 82 2 levels level NOUN iajs-53 82 3 for for ADP iajs-53 82 4 g2&g3 g2&g3 PROPN iajs-53 82 5 was be AUX iajs-53 82 6 ( ( PUNCT iajs-53 82 7 15.79±1.45ng 15.79±1.45ng NUM iajs-53 82 8 / / SYM iajs-53 82 9 ml)(17.46±1.09ng ml)(17.46±1.09ng PROPN iajs-53 82 10 / / PUNCT iajs-53 82 11 ml)respectively ml)respectively ADV iajs-53 82 12 compared compare VERB iajs-53 82 13 with with ADP iajs-53 82 14 g1(2.32±1.11ng g1(2.32±1.11ng PROPN iajs-53 82 15 / / SYM iajs-53 82 16 ml ml NOUN iajs-53 82 17 ) ) PUNCT iajs-53 82 18 . . PUNCT iajs-53 83 1 no no DET iajs-53 83 2 significant significant ADJ iajs-53 83 3 elevation elevation NOUN iajs-53 83 4 between between ADP iajs-53 83 5 g2&g3 g2&g3 PROPN iajs-53 83 6 was be AUX iajs-53 83 7 noticed notice VERB iajs-53 83 8 . . PUNCT iajs-53 84 1 homeostasis homeostasis NOUN iajs-53 84 2 insulin insulin NOUN iajs-53 84 3 resistance resistance NOUN iajs-53 84 4 ( ( PUNCT iajs-53 84 5 homair homair NOUN iajs-53 84 6 ) ) PUNCT iajs-53 84 7 was be AUX iajs-53 84 8 significantly significantly ADV iajs-53 84 9 increased increase VERB iajs-53 84 10 in in ADP iajs-53 84 11 g2&g3(6.67±0.70)(8.58±0.79 g2&g3(6.67±0.70)(8.58±0.79 NOUN iajs-53 84 12 ) ) PUNCT iajs-53 84 13 respectively respectively ADV iajs-53 84 14 compared compare VERB iajs-53 84 15 with with ADP iajs-53 84 16 g1(2.7±0.28 g1(2.7±0.28 NOUN iajs-53 84 17 ) ) PUNCT iajs-53 84 18 . . PUNCT iajs-53 85 1 no no DET iajs-53 85 2 significant significant ADJ iajs-53 85 3 elevation elevation NOUN iajs-53 85 4 between between ADP iajs-53 85 5 g2&g3 g2&g3 PROPN iajs-53 85 6 was be AUX iajs-53 85 7 noticed notice VERB iajs-53 85 8 . . PUNCT iajs-53 86 1 dyslipidemia dyslipidemia NOUN iajs-53 86 2 and and CCONJ iajs-53 86 3 insulin insulin NOUN iajs-53 86 4 resistance resistance NOUN iajs-53 86 5 are be AUX iajs-53 86 6 both both PRON iajs-53 86 7 considered consider VERB iajs-53 86 8 to to PART iajs-53 86 9 be be AUX iajs-53 86 10 risk risk NOUN iajs-53 86 11 factors factor NOUN iajs-53 86 12 for for ADP iajs-53 86 13 metabolic metabolic NOUN iajs-53 86 14 syndrome syndrome NOUN iajs-53 86 15 , , PUNCT iajs-53 86 16 insulin insulin NOUN iajs-53 86 17 resistance resistance NOUN iajs-53 86 18 are be AUX iajs-53 86 19 associated associate VERB iajs-53 86 20 with with ADP iajs-53 86 21 low low ADJ iajs-53 86 22 igf-1 igf-1 NOUN iajs-53 86 23 level level NOUN iajs-53 86 24 , , PUNCT iajs-53 86 25 depression depression NOUN iajs-53 86 26 of of ADP iajs-53 86 27 hdl hdl PROPN iajs-53 86 28 - - PUNCT iajs-53 86 29 c c NOUN iajs-53 86 30 concomitant concomitant NOUN iajs-53 86 31 with with ADP iajs-53 86 32 elevation elevation NOUN iajs-53 86 33 of of ADP iajs-53 86 34 ldl ldl NOUN iajs-53 86 35 - - PUNCT iajs-53 86 36 c c PROPN iajs-53 86 37 , , PUNCT iajs-53 86 38 increasing increase VERB iajs-53 86 39 risk risk NOUN iajs-53 86 40 of of ADP iajs-53 86 41 obesity obesity NOUN iajs-53 86 42 and and CCONJ iajs-53 86 43 type2 type2 PROPN iajs-53 86 44 diabetes[30 diabetes[30 PROPN iajs-53 86 45 ] ] PUNCT iajs-53 86 46 . . PUNCT iajs-53 87 1 low low ADJ iajs-53 87 2 igf-1 igf-1 PRON iajs-53 87 3 level level NOUN iajs-53 87 4 was be AUX iajs-53 87 5 found find VERB iajs-53 87 6 in in ADP iajs-53 87 7 diabetic diabetic ADJ iajs-53 87 8 patients patient NOUN iajs-53 87 9 which which PRON iajs-53 87 10 have have AUX iajs-53 87 11 been be AUX iajs-53 87 12 discovered discover VERB iajs-53 87 13 to to PART iajs-53 87 14 be be AUX iajs-53 87 15 associated associate VERB iajs-53 87 16 with with ADP iajs-53 87 17 insulin insulin NOUN iajs-53 87 18 resistance[4 resistance[4 NOUN iajs-53 87 19 ] ] PUNCT iajs-53 87 20 . . PUNCT iajs-53 88 1 the the DET iajs-53 88 2 action action NOUN iajs-53 88 3 of of ADP iajs-53 88 4 igf-1 igf-1 NOUN iajs-53 88 5 is be AUX iajs-53 88 6 directly directly ADV iajs-53 88 7 on on ADP iajs-53 88 8 the the DET iajs-53 88 9 balance balance NOUN iajs-53 88 10 between between ADP iajs-53 88 11 gh gh PROPN iajs-53 88 12 and and CCONJ iajs-53 88 13 insulin insulin NOUN iajs-53 88 14 to to ADP iajs-53 88 15 the the DET iajs-53 88 16 control control NOUN iajs-53 88 17 of of ADP iajs-53 88 18 glucose glucose NOUN iajs-53 88 19 homeostasis homeostasis NOUN iajs-53 88 20 [ [ X iajs-53 88 21 31 31 NUM iajs-53 88 22 ] ] PUNCT iajs-53 88 23 . . PUNCT iajs-53 89 1 conclusions conclusion NOUN iajs-53 89 2 the the DET iajs-53 89 3 results result NOUN iajs-53 89 4 of of ADP iajs-53 89 5 the the DET iajs-53 89 6 present present ADJ iajs-53 89 7 study study NOUN iajs-53 89 8 indicate indicate VERB iajs-53 89 9 that that SCONJ iajs-53 89 10 there there PRON iajs-53 89 11 is be VERB iajs-53 89 12 no no DET iajs-53 89 13 effect effect NOUN iajs-53 89 14 of of ADP iajs-53 89 15 dyslipidemia dyslipidemia NOUN iajs-53 89 16 on on ADP iajs-53 89 17 igf-1 igf-1 NOUN iajs-53 89 18 level level NOUN iajs-53 89 19 which which PRON iajs-53 89 20 there there PRON iajs-53 89 21 are be VERB iajs-53 89 22 no no DET iajs-53 89 23 significant significant ADJ iajs-53 89 24 redaction redaction NOUN iajs-53 89 25 found find VERB iajs-53 89 26 between between ADP iajs-53 89 27 controlled control VERB iajs-53 89 28 and and CCONJ iajs-53 89 29 uncontrolled uncontrolled ADJ iajs-53 89 30 dyslipidemia dyslipidemia NOUN iajs-53 89 31 diabetic diabetic ADJ iajs-53 89 32 patients patient NOUN iajs-53 89 33 . . PUNCT iajs-53 90 1 references reference NOUN iajs-53 90 2 1 1 NUM iajs-53 90 3 . . PUNCT iajs-53 91 1 baynes baynes PROPN iajs-53 91 2 , , PUNCT iajs-53 91 3 j. j. PROPN iajs-53 91 4 , , PUNCT iajs-53 91 5 and and CCONJ iajs-53 91 6 dominiczak dominiczak NOUN iajs-53 91 7 , , PUNCT iajs-53 91 8 m.(2004 m.(2004 PROPN iajs-53 91 9 ) ) PUNCT iajs-53 91 10 . . PUNCT iajs-53 92 1 glucose glucose NOUN iajs-53 92 2 homeostasis homeostasis NOUN iajs-53 92 3 and and CCONJ iajs-53 92 4 fuel fuel NOUN iajs-53 92 5 metabolism metabolism NOUN iajs-53 92 6 . . PUNCT iajs-53 93 1 in in ADP iajs-53 93 2 : : PUNCT iajs-53 93 3 medical medical ADJ iajs-53 93 4 biochemistr biochemistr NOUN iajs-53 93 5 . . PUNCT iajs-53 94 1 mosby mosby PROPN iajs-53 94 2 ltd;2:243–266 ltd;2:243–266 PROPN iajs-53 94 3 . . PUNCT iajs-53 95 1 2 2 X iajs-53 95 2 . . X iajs-53 95 3 kabir kabir PROPN iajs-53 95 4 , , PUNCT iajs-53 95 5 g. g. PROPN iajs-53 95 6 ; ; PUNCT iajs-53 95 7 hossain hossain PROPN iajs-53 95 8 , , PUNCT iajs-53 95 9 m m PROPN iajs-53 95 10 . . PUNCT iajs-53 95 11 ; ; PUNCT iajs-53 95 12 faruqe faruqe PROPN iajs-53 95 13 , , PUNCT iajs-53 95 14 o. o. INTJ iajs-53 95 15 ; ; PUNCT iajs-53 95 16 alauddin alauddin NOUN iajs-53 95 17 , , PUNCT iajs-53 95 18 m. m. NOUN iajs-53 95 19 ; ; PUNCT iajs-53 95 20 and and CCONJ iajs-53 95 21 ali ali PROPN iajs-53 95 22 , , PUNCT iajs-53 95 23 l. l. PROPN iajs-53 95 24 ( ( PUNCT iajs-53 95 25 2014 2014 NUM iajs-53 95 26 ) ) PUNCT iajs-53 95 27 association association NOUN iajs-53 95 28 of of ADP iajs-53 95 29 serum serum PROPN iajs-53 95 30 free free ADJ iajs-53 95 31 igf-1 igf-1 ADV iajs-53 95 32 and and CCONJ iajs-53 95 33 igfbp-1 igfbp-1 NUM iajs-53 95 34 with with ADP iajs-53 95 35 insulin insulin NOUN iajs-53 95 36 sensitivity sensitivity NOUN iajs-53 95 37 and and CCONJ iajs-53 95 38 insulin insulin NOUN iajs-53 95 39 secretory secretory ADJ iajs-53 95 40 defects defect NOUN iajs-53 95 41 in in ADP iajs-53 95 42 bangladeshi bangladeshi PROPN iajs-53 95 43 type2 type2 PROPN iajs-53 95 44 diabetes diabetes PROPN iajs-53 95 45 mellitus mellitus NOUN iajs-53 95 46 . . PUNCT iajs-53 96 1 jou jou INTJ iajs-53 96 2 of of ADP iajs-53 96 3 taibah taibah PROPN iajs-53 96 4 university university PROPN iajs-53 96 5 medical medical ADJ iajs-53 96 6 sciences science NOUN iajs-53 96 7 ; ; PUNCT iajs-53 96 8 9(2 9(2 NUM iajs-53 96 9 ): ): PUNCT iajs-53 96 10 132 132 NUM iajs-53 96 11 - - SYM iajs-53 96 12 138 138 NUM iajs-53 96 13 . . PUNCT iajs-53 97 1 3 3 X iajs-53 97 2 . . X iajs-53 97 3 kwasniewski kwasniewski PROPN iajs-53 97 4 , , PUNCT iajs-53 97 5 w. w. PROPN iajs-53 97 6 ; ; PUNCT iajs-53 97 7 kotarski kotarski PROPN iajs-53 97 8 , , PUNCT iajs-53 97 9 j. j. PROPN iajs-53 97 10 ; ; PUNCT iajs-53 97 11 polak polak PROPN iajs-53 97 12 , , PUNCT iajs-53 97 13 g.;and g.;and PROPN iajs-53 97 14 cozdzieka cozdzieka PROPN iajs-53 97 15 - - PUNCT iajs-53 97 16 jozifica jozifica PROPN iajs-53 97 17 . . PUNCT iajs-53 98 1 ( ( PUNCT iajs-53 98 2 2014 2014 NUM iajs-53 98 3 ) ) PUNCT iajs-53 98 4 . . PUNCT iajs-53 99 1 the the DET iajs-53 99 2 role role NOUN iajs-53 99 3 of of ADP iajs-53 99 4 human human ADJ iajs-53 99 5 insulin insulin NOUN iajs-53 99 6 growth growth NOUN iajs-53 99 7 factor factor NOUN iajs-53 99 8 ( ( PUNCT iajs-53 99 9 igf)-axis igf)-axi VERB iajs-53 99 10 in in ADP iajs-53 99 11 carcinogenesis carcinogenesis NOUN iajs-53 99 12 .advances .advances PUNCT iajs-53 99 13 in in ADP iajs-53 99 14 cell cell NOUN iajs-53 99 15 biology;4:25 biology;4:25 NOUN iajs-53 99 16 - - SYM iajs-53 99 17 42 42 NUM iajs-53 99 18 . . PUNCT iajs-53 100 1 4.takano 4.takano PROPN iajs-53 100 2 , , PUNCT iajs-53 100 3 a. a. NOUN iajs-53 100 4 ; ; PUNCT iajs-53 100 5 usni usni ADJ iajs-53 100 6 , , PUNCT iajs-53 100 7 i.;haruta i.;haruta ADJ iajs-53 100 8 , , PUNCT iajs-53 100 9 t. t. PROPN iajs-53 100 10 ; ; PUNCT iajs-53 100 11 kawahara kawahara PROPN iajs-53 100 12 , , PUNCT iajs-53 100 13 j. j. PROPN iajs-53 100 14 ; ; PUNCT iajs-53 100 15 uno uno PROPN iajs-53 100 16 , , PUNCT iajs-53 100 17 t. t. PROPN iajs-53 100 18 ; ; PUNCT iajs-53 100 19 iawata iawata VERB iajs-53 100 20 , , PUNCT iajs-53 100 21 m&kobayashi m&kobayashi NUM iajs-53 100 22 , , PUNCT iajs-53 100 23 m. m. NOUN iajs-53 100 24 ( ( PUNCT iajs-53 100 25 2001 2001 NUM iajs-53 100 26 ) ) PUNCT iajs-53 100 27 . . PUNCT iajs-53 101 1 mammalian mammalian ADJ iajs-53 101 2 target target NOUN iajs-53 101 3 of of ADP iajs-53 101 4 kanamycin kanamycin PROPN iajs-53 101 5 pathway pathway NOUN iajs-53 101 6 regulates regulate VERB iajs-53 101 7 insulin insulin NOUN iajs-53 101 8 signaling signal VERB iajs-53 101 9 via via ADP iajs-53 101 10 subcellular subcellular ADJ iajs-53 101 11 redistribution redistribution NOUN iajs-53 101 12 of of ADP iajs-53 101 13 insulin insulin NOUN iajs-53 101 14 receptor receptor NOUN iajs-53 101 15 substrate substrate NOUN iajs-53 101 16 and and CCONJ iajs-53 101 17 integrates integrate VERB iajs-53 101 18 nutritional nutritional ADJ iajs-53 101 19 signals signal NOUN iajs-53 101 20 and and CCONJ iajs-53 101 21 metabolic metabolic NOUN iajs-53 101 22 signal signal NOUN iajs-53 101 23 at at ADP iajs-53 101 24 insulin insulin NOUN iajs-53 101 25 . . PUNCT iajs-53 102 1 molecular molecular ADJ iajs-53 102 2 and and CCONJ iajs-53 102 3 cellular cellular ADJ iajs-53 102 4 biology;21:5050 biology;21:5050 PROPN iajs-53 102 5 - - PUNCT iajs-53 102 6 5062 5062 NUM iajs-53 102 7 . . PUNCT iajs-53 103 1 5.yadav 5.yadav NUM iajs-53 103 2 , , PUNCT iajs-53 103 3 a.;jyoti a.;jyoti PROPN iajs-53 103 4 , , PUNCT iajs-53 103 5 pp.;and pp.;and PROPN iajs-53 103 6 jain jain PROPN iajs-53 103 7 , , PUNCT iajs-53 103 8 s. s. PROPN iajs-53 103 9 ( ( PUNCT iajs-53 103 10 2011 2011 NUM iajs-53 103 11 ) ) PUNCT iajs-53 103 12 . . PUNCT iajs-53 104 1 correlation correlation NOUN iajs-53 104 2 of of ADP iajs-53 104 3 adiponectin adiponectin NOUN iajs-53 104 4 and and CCONJ iajs-53 104 5 leptin leptin NOUN iajs-53 104 6 with with ADP iajs-53 104 7 insulin insulin NOUN iajs-53 104 8 resistance resistance NOUN iajs-53 104 9 : : PUNCT iajs-53 104 10 a a DET iajs-53 104 11 pilot pilot NOUN iajs-53 104 12 study study NOUN iajs-53 104 13 in in ADP iajs-53 104 14 healthy healthy ADJ iajs-53 104 15 north north PROPN iajs-53 104 16 indian indian ADJ iajs-53 104 17 population population NOUN iajs-53 104 18 . . PUNCT iajs-53 105 1 ind ind PROPN iajs-53 105 2 .j .j PROPN iajs-53 105 3 . . PUNCT iajs-53 106 1 clin clin PROPN iajs-53 106 2 . . PUNCT iajs-53 107 1 biochem biochem PROPN iajs-53 107 2 ; ; PUNCT iajs-53 107 3 26(2):165193 26(2):165193 NUM iajs-53 107 4 . . PUNCT iajs-53 108 1 6.colao 6.colao NUM iajs-53 108 2 , , PUNCT iajs-53 108 3 a. a. NOUN iajs-53 108 4 ; ; PUNCT iajs-53 108 5 disomma disomma PROPN iajs-53 108 6 , , PUNCT iajs-53 108 7 c. c. NOUN iajs-53 108 8 ; ; PUNCT iajs-53 108 9 cascella cascella NOUN iajs-53 108 10 , , PUNCT iajs-53 108 11 t. t. PROPN iajs-53 108 12 ; ; PUNCT iajs-53 108 13 pivonello pivonello PROPN iajs-53 108 14 , , PUNCT iajs-53 108 15 r.;vitale r.;vitale NOUN iajs-53 108 16 , , PUNCT iajs-53 108 17 g. g. PROPN iajs-53 108 18 ; ; PUNCT iajs-53 108 19 grasso grasso PROPN iajs-53 108 20 , , PUNCT iajs-53 108 21 lfs lfs PROPN iajs-53 108 22 . . PUNCT iajs-53 108 23 ; ; PUNCT iajs-53 108 24 lombardi lombardi PROPN iajs-53 108 25 , , PUNCT iajs-53 108 26 g. g. PROPN iajs-53 108 27 ; ; PUNCT iajs-53 108 28 and and CCONJ iajs-53 108 29 savasstano savasstano PROPN iajs-53 108 30 , , PUNCT iajs-53 108 31 s. s. PROPN iajs-53 108 32 ( ( PUNCT iajs-53 108 33 2008 2008 NUM iajs-53 108 34 ) ) PUNCT iajs-53 108 35 . . PUNCT iajs-53 109 1 relationship relationship NOUN iajs-53 109 2 between between ADP iajs-53 109 3 serum serum NOUN iajs-53 109 4 igf-1 igf-1 NOUN iajs-53 109 5 level level NOUN iajs-53 109 6 , , PUNCT iajs-53 109 7 blood blood NOUN iajs-53 109 8 pressure pressure NOUN iajs-53 109 9 and and CCONJ iajs-53 109 10 glucose glucose NOUN iajs-53 109 11 tolerance tolerance NOUN iajs-53 109 12 : : PUNCT iajs-53 109 13 an an DET iajs-53 109 14 observational observational ADJ iajs-53 109 15 , , PUNCT iajs-53 109 16 exploratory exploratory ADJ iajs-53 109 17 study study NOUN iajs-53 109 18 in in ADP iajs-53 109 19 404 404 NUM iajs-53 109 20 subjects subject NOUN iajs-53 109 21 . . PUNCT iajs-53 110 1 eur.jou.of eur.jou.of PROPN iajs-53 110 2 endocrinology endocrinology NOUN iajs-53 110 3 ; ; PUNCT iajs-53 110 4 159:389 159:389 NUM iajs-53 110 5 - - PUNCT iajs-53 110 6 397 397 NUM iajs-53 110 7 . . NOUN iajs-53 110 8 129 129 NUM iajs-53 111 1 | | ADV iajs-53 111 2 chemistry chemistry NOUN iajs-53 111 3 2016عام 2016عام NOUN iajs-53 111 4 ) ) PUNCT iajs-53 112 1 1(العدد 1(العدد NUM iajs-53 112 2 29لمجلد 29لمجلد NUM iajs-53 113 1 ا ا X iajs-53 114 1 مجلة مجلة ADJ iajs-53 114 2 إبن إبن VERB iajs-53 114 3 الهيثم الهيثم ADJ iajs-53 114 4 للعلوم للعلوم NOUN iajs-53 114 5 الصرفة الصرفة NOUN iajs-53 115 1 و و PRON iajs-53 115 2 التطبيقية التطبيقية ADJ iajs-53 115 3 ibn ibn PROPN iajs-53 115 4 al al PROPN iajs-53 115 5 - - PUNCT iajs-53 115 6 haitham haitham PROPN iajs-53 115 7 jour jour X iajs-53 115 8 . . PROPN iajs-53 115 9 for for ADP iajs-53 115 10 pure pure ADJ iajs-53 115 11 & & CCONJ iajs-53 115 12 appl appl PROPN iajs-53 115 13 . . PUNCT iajs-53 116 1 sci sci PROPN iajs-53 116 2 . . PUNCT iajs-53 116 3 vol vol NOUN iajs-53 116 4 . . PROPN iajs-53 116 5 29 29 NUM iajs-53 117 1 ( ( PUNCT iajs-53 117 2 1 1 NUM iajs-53 117 3 ) ) PUNCT iajs-53 117 4 2016 2016 NUM iajs-53 117 5 7.tago 7.tago NUM iajs-53 117 6 , , PUNCT iajs-53 117 7 dn dn PROPN iajs-53 117 8 . . PROPN iajs-53 117 9 ; ; PUNCT iajs-53 117 10 amo amo PROPN iajs-53 117 11 - - PUNCT iajs-53 117 12 kodieh kodieh PROPN iajs-53 117 13 , , PUNCT iajs-53 117 14 p. p. NOUN iajs-53 117 15 ( ( PUNCT iajs-53 117 16 2013 2013 NUM iajs-53 117 17 ) ) PUNCT iajs-53 117 18 . . PUNCT iajs-53 118 1 type2 type2 PROPN iajs-53 118 2 diabetes diabetes NOUN iajs-53 118 3 mellitus mellitus NOUN iajs-53 118 4 influences influence VERB iajs-53 118 5 lipid lipid NOUN iajs-53 118 6 profile profile NOUN iajs-53 118 7 of of ADP iajs-53 118 8 diabetic diabetic ADJ iajs-53 118 9 patients patient NOUN iajs-53 118 10 . . PUNCT iajs-53 119 1 annal annal ADJ iajs-53 119 2 of of ADP iajs-53 119 3 biological biological ADJ iajs-53 119 4 research research NOUN iajs-53 119 5 ; ; PUNCT iajs-53 119 6 4(6):88 4(6):88 PROPN iajs-53 119 7 - - PUNCT iajs-53 119 8 92 92 NUM iajs-53 119 9 . . PUNCT iajs-53 120 1 8.songa 8.songa NUM iajs-53 120 2 , , PUNCT iajs-53 120 3 rm rm NOUN iajs-53 120 4 . . PUNCT iajs-53 120 5 ; ; PUNCT iajs-53 120 6 siddhartha siddhartha PROPN iajs-53 120 7 , , PUNCT iajs-53 120 8 k. k. PROPN iajs-53 120 9 ; ; PUNCT iajs-53 120 10 and and CCONJ iajs-53 120 11 sudhakar sudhakar PROPN iajs-53 120 12 , , PUNCT iajs-53 120 13 k. k. PROPN iajs-53 120 14 ( ( PUNCT iajs-53 120 15 2013 2013 NUM iajs-53 120 16 ) ) PUNCT iajs-53 120 17 . . PUNCT iajs-53 121 1 lipidprofile lipidprofile ADJ iajs-53 121 2 in in ADP iajs-53 121 3 type2 type2 PROPN iajs-53 121 4 diabetes diabetes NOUN iajs-53 121 5 mellitus mellitus NOUN iajs-53 121 6 with with ADP iajs-53 121 7 obesity obesity NOUN iajs-53 121 8 . . PUNCT iajs-53 122 1 bulletin bulletin NOUN iajs-53 122 2 of of ADP iajs-53 122 3 pharmaceutical pharmaceutical NOUN iajs-53 122 4 and and CCONJ iajs-53 122 5 medical medical ADJ iajs-53 122 6 sciences science NOUN iajs-53 122 7 ( ( PUNCT iajs-53 122 8 bopams bopam NOUN iajs-53 122 9 ) ) PUNCT iajs-53 122 10 ; ; PUNCT iajs-53 122 11 1(2):132 1(2):132 NUM iajs-53 122 12 - - SYM iajs-53 122 13 137 137 NUM iajs-53 122 14 . . PUNCT iajs-53 123 1 9.mgonda 9.mgonda NUM iajs-53 123 2 , , PUNCT iajs-53 123 3 ym ym PROPN iajs-53 123 4 . . PUNCT iajs-53 123 5 ; ; PUNCT iajs-53 123 6 ramaiya ramaiya PROPN iajs-53 123 7 , , PUNCT iajs-53 123 8 ki ki PROPN iajs-53 123 9 . . PUNCT iajs-53 123 10 ; ; PUNCT iajs-53 123 11 swai swai PROPN iajs-53 123 12 , , PUNCT iajs-53 123 13 abm abm PROPN iajs-53 123 14 . . PUNCT iajs-53 123 15 ; ; PUNCT iajs-53 123 16 mclarity mclarity NOUN iajs-53 123 17 , , PUNCT iajs-53 123 18 dg.;and dg.;and PROPN iajs-53 123 19 albert albert PROPN iajs-53 123 20 , , PUNCT iajs-53 123 21 kgm kgm PROPN iajs-53 123 22 . . PUNCT iajs-53 123 23 ( ( PUNCT iajs-53 123 24 1998 1998 NUM iajs-53 123 25 ) ) PUNCT iajs-53 123 26 . . PUNCT iajs-53 124 1 hypertension hypertension NOUN iajs-53 124 2 ; ; PUNCT iajs-53 124 3 31:114 31:114 NUM iajs-53 124 4 - - SYM iajs-53 124 5 118 118 NUM iajs-53 124 6 . . PUNCT iajs-53 125 1 10.barham 10.barham NUM iajs-53 125 2 , , PUNCT iajs-53 125 3 d. d. PROPN iajs-53 125 4 ; ; PUNCT iajs-53 125 5 and and CCONJ iajs-53 125 6 trindor trindor NOUN iajs-53 125 7 , , PUNCT iajs-53 125 8 p p X iajs-53 125 9 . . PUNCT iajs-53 126 1 ( ( PUNCT iajs-53 126 2 1972 1972 NUM iajs-53 126 3 ) ) PUNCT iajs-53 126 4 . . PUNCT iajs-53 127 1 an an DET iajs-53 127 2 improved improved ADJ iajs-53 127 3 color color NOUN iajs-53 127 4 reagent reagent NOUN iajs-53 127 5 from from ADP iajs-53 127 6 the the DET iajs-53 127 7 determination determination NOUN iajs-53 127 8 of of ADP iajs-53 127 9 blood blood NOUN iajs-53 127 10 glucose glucose NOUN iajs-53 127 11 by by ADP iajs-53 127 12 the the DET iajs-53 127 13 oxidation oxidation NOUN iajs-53 127 14 system system NOUN iajs-53 127 15 . . PUNCT iajs-53 128 1 analyst analyst NOUN iajs-53 128 2 . . PUNCT iajs-53 129 1 97 97 NUM iajs-53 129 2 : : SYM iajs-53 129 3 142 142 NUM iajs-53 129 4 - - SYM iajs-53 129 5 145 145 NUM iajs-53 129 6 . . PUNCT iajs-53 130 1 11 11 NUM iajs-53 130 2 . . PUNCT iajs-53 131 1 richmond richmond PROPN iajs-53 131 2 , , PUNCT iajs-53 131 3 w. w. PROPN iajs-53 131 4 ( ( PUNCT iajs-53 131 5 1974 1974 NUM iajs-53 131 6 ) ) PUNCT iajs-53 131 7 . . PUNCT iajs-53 132 1 proceeding proceed VERB iajs-53 132 2 in in ADP iajs-53 132 3 the the DET iajs-53 132 4 development development NOUN iajs-53 132 5 of of ADP iajs-53 132 6 an an DET iajs-53 132 7 enzymatic enzymatic ADJ iajs-53 132 8 technique technique NOUN iajs-53 132 9 for for ADP iajs-53 132 10 the the DET iajs-53 132 11 assay assay NOUN iajs-53 132 12 at at ADP iajs-53 132 13 cholesterol cholesterol NOUN iajs-53 132 14 in in ADP iajs-53 132 15 biological biological ADJ iajs-53 132 16 fluids fluid NOUN iajs-53 132 17 . . PUNCT iajs-53 133 1 clin.sci.mol.med clin.sci.mol.me VERB iajs-53 133 2 . . PUNCT iajs-53 134 1 46 46 NUM iajs-53 134 2 - - SYM iajs-53 134 3 67 67 NUM iajs-53 134 4 . . PUNCT iajs-53 135 1 12.buristein 12.buristein NUM iajs-53 135 2 , , PUNCT iajs-53 135 3 m. m. NOUN iajs-53 135 4 ; ; PUNCT iajs-53 135 5 osbar osbar NOUN iajs-53 135 6 , , PUNCT iajs-53 135 7 a. a. NOUN iajs-53 135 8 ; ; PUNCT iajs-53 135 9 laki laki PROPN iajs-53 135 10 , , PUNCT iajs-53 135 11 k.;and k.;and PROPN iajs-53 135 12 jensen jensen PROPN iajs-53 135 13 , , PUNCT iajs-53 135 14 js js PROPN iajs-53 135 15 . . PUNCT iajs-53 136 1 ( ( PUNCT iajs-53 136 2 1970 1970 NUM iajs-53 136 3 ) ) PUNCT iajs-53 136 4 . . PUNCT iajs-53 137 1 rapid rapid ADJ iajs-53 137 2 method method NOUN iajs-53 137 3 for for ADP iajs-53 137 4 the the DET iajs-53 137 5 isolation isolation NOUN iajs-53 137 6 of of ADP iajs-53 137 7 lipoproteins lipoprotein NOUN iajs-53 137 8 from from ADP iajs-53 137 9 human human ADJ iajs-53 137 10 serum serum NOUN iajs-53 137 11 by by ADP iajs-53 137 12 precipitation precipitation NOUN iajs-53 137 13 poly poly ADJ iajs-53 137 14 anions anion NOUN iajs-53 137 15 . . PUNCT iajs-53 138 1 lipid lipid NOUN iajs-53 138 2 res re NOUN iajs-53 138 3 ; ; PUNCT iajs-53 138 4 11:583 11:583 NUM iajs-53 138 5 - - SYM iajs-53 138 6 595 595 NUM iajs-53 138 7 . . PUNCT iajs-53 139 1 13 13 NUM iajs-53 139 2 . . PUNCT iajs-53 140 1 fossati fossati PROPN iajs-53 140 2 , , PUNCT iajs-53 140 3 p.;and p.;and NOUN iajs-53 140 4 prencipe prencipe PROPN iajs-53 140 5 , , PUNCT iajs-53 140 6 l. l. PROPN iajs-53 140 7 ( ( PUNCT iajs-53 140 8 1982 1982 NUM iajs-53 140 9 ) ) PUNCT iajs-53 140 10 . . PUNCT iajs-53 141 1 measurement measurement NOUN iajs-53 141 2 of of ADP iajs-53 141 3 serum serum NOUN iajs-53 141 4 triglyceride triglyceride ADP iajs-53 141 5 calorimetrically calorimetrically ADV iajs-53 141 6 with with ADP iajs-53 141 7 an an DET iajs-53 141 8 enzyme enzyme NOUN iajs-53 141 9 that that PRON iajs-53 141 10 produce produce VERB iajs-53 141 11 h2o2 h2o2 NOUN iajs-53 141 12 . . PUNCT iajs-53 142 1 clin clin PROPN iajs-53 142 2 .chem .chem PROPN iajs-53 142 3 ; ; PUNCT iajs-53 142 4 28(10):2077 28(10):2077 NUM iajs-53 142 5 - - SYM iajs-53 142 6 2088 2088 NUM iajs-53 142 7 . . PUNCT iajs-53 143 1 14 14 NUM iajs-53 143 2 . . X iajs-53 143 3 fridewald fridewald PROPN iajs-53 143 4 , , PUNCT iajs-53 143 5 wt.;levy wt.;levy PROPN iajs-53 143 6 , , PUNCT iajs-53 143 7 ri.;and ri.;and PROPN iajs-53 143 8 fredrickson fredrickson PROPN iajs-53 143 9 , , PUNCT iajs-53 143 10 ds.(1972 ds.(1972 PROPN iajs-53 143 11 ) ) PUNCT iajs-53 143 12 estimation estimation NOUN iajs-53 143 13 of of ADP iajs-53 143 14 the the DET iajs-53 143 15 concentration concentration NOUN iajs-53 143 16 of of ADP iajs-53 143 17 iow iow PROPN iajs-53 143 18 - - PUNCT iajs-53 143 19 density density NOUN iajs-53 143 20 lipoprotein lipoprotein ADJ iajs-53 143 21 cholesterol cholesterol NOUN iajs-53 143 22 in in ADP iajs-53 143 23 plasma plasma NOUN iajs-53 143 24 , , PUNCT iajs-53 143 25 without without ADP iajs-53 143 26 use use NOUN iajs-53 143 27 of of ADP iajs-53 143 28 the the DET iajs-53 143 29 preparative preparative NOUN iajs-53 143 30 . . PUNCT iajs-53 144 1 clin clin PROPN iajs-53 144 2 chem chem PROPN iajs-53 144 3 . . PUNCT iajs-53 145 1 81:499 81:499 NUM iajs-53 145 2 - - SYM iajs-53 145 3 502 502 NUM iajs-53 145 4 . . NOUN iajs-53 146 1 15 15 NUM iajs-53 146 2 frier frier NOUN iajs-53 146 3 , , PUNCT iajs-53 146 4 bm bm PROPN iajs-53 146 5 . . PROPN iajs-53 146 6 ; ; PUNCT iajs-53 146 7 ashby ashby PROPN iajs-53 146 8 , , PUNCT iajs-53 146 9 jp jp PROPN iajs-53 146 10 . . PROPN iajs-53 146 11 ; ; PUNCT iajs-53 146 12 nairn nairn PROPN iajs-53 146 13 , , PUNCT iajs-53 146 14 i i PRON iajs-53 146 15 m. m. NOUN iajs-53 146 16 ; ; PUNCT iajs-53 146 17 and and CCONJ iajs-53 146 18 baris baris PROPN iajs-53 146 19 , , PUNCT iajs-53 146 20 jd jd PROPN iajs-53 146 21 . . PROPN iajs-53 146 22 ( ( PUNCT iajs-53 146 23 1981 1981 NUM iajs-53 146 24 ) ) PUNCT iajs-53 146 25 . . PUNCT iajs-53 147 1 plasma plasma NOUN iajs-53 147 2 insulinpeptide insulinpeptide ADV iajs-53 147 3 and and CCONJ iajs-53 147 4 glucagon glucagon NOUN iajs-53 147 5 concentration concentration NOUN iajs-53 147 6 in in ADP iajs-53 147 7 patients patient NOUN iajs-53 147 8 with with ADP iajs-53 147 9 insulin insulin NOUN iajs-53 147 10 independent independent ADJ iajs-53 147 11 diabetes diabetes NOUN iajs-53 147 12 treated treat VERB iajs-53 147 13 with with ADP iajs-53 147 14 chlorpropamide chlorpropamide NOUN iajs-53 147 15 . . PUNCT iajs-53 148 1 diabet.metab diabet.metab NOUN iajs-53 148 2 ; ; PUNCT iajs-53 148 3 7(1):49 7(1):49 X iajs-53 148 4 - - SYM iajs-53 148 5 9 9 NUM iajs-53 148 6 . . PUNCT iajs-53 148 7 16.matthews 16.matthews NUM iajs-53 148 8 , , PUNCT iajs-53 148 9 dr dr PROPN iajs-53 148 10 . . PROPN iajs-53 148 11 ; ; PUNCT iajs-53 148 12 hosker hosker NOUN iajs-53 148 13 , , PUNCT iajs-53 148 14 jp jp PROPN iajs-53 148 15 . . PUNCT iajs-53 148 16 ; ; PUNCT iajs-53 148 17 rudenski rudenski NOUN iajs-53 148 18 , , PUNCT iajs-53 148 19 as as ADP iajs-53 148 20 . . PROPN iajs-53 148 21 ; ; PUNCT iajs-53 148 22 naylor naylor PROPN iajs-53 148 23 , , PUNCT iajs-53 148 24 ba ba PROPN iajs-53 148 25 . . PROPN iajs-53 148 26 ; ; PUNCT iajs-53 148 27 treacher treacher PROPN iajs-53 148 28 , , PUNCT iajs-53 148 29 df.;and df.;and PROPN iajs-53 148 30 turner turner PROPN iajs-53 148 31 , , PUNCT iajs-53 148 32 rc rc PROPN iajs-53 148 33 . . PROPN iajs-53 148 34 ( ( PUNCT iajs-53 148 35 1985 1985 NUM iajs-53 148 36 ) ) PUNCT iajs-53 148 37 . . PUNCT iajs-53 149 1 homeostasis homeostasis NOUN iajs-53 149 2 modle modle NOUN iajs-53 149 3 assessment assessment NOUN iajs-53 149 4 : : PUNCT iajs-53 149 5 insulin insulin NOUN iajs-53 149 6 risistance risistance NOUN iajs-53 149 7 and and CCONJ iajs-53 149 8 beta beta NOUN iajs-53 149 9 - - PUNCT iajs-53 149 10 cell cell NOUN iajs-53 149 11 function function NOUN iajs-53 149 12 from from ADP iajs-53 149 13 fasting fast VERB iajs-53 149 14 plasma plasma NOUN iajs-53 149 15 glucose glucose NOUN iajs-53 149 16 and and CCONJ iajs-53 149 17 insulin insulin NOUN iajs-53 149 18 concentration concentration NOUN iajs-53 149 19 in in ADP iajs-53 149 20 man man NOUN iajs-53 149 21 . . PUNCT iajs-53 150 1 diabetologia diabetologia NOUN iajs-53 150 2 ; ; PUNCT iajs-53 150 3 28:412 28:412 NUM iajs-53 150 4 - - SYM iajs-53 150 5 419 419 NUM iajs-53 150 6 . . PUNCT iajs-53 151 1 17 17 NUM iajs-53 151 2 . . PUNCT iajs-53 152 1 ikewnch ikewnch PROPN iajs-53 152 2 , , PUNCT iajs-53 152 3 c.;and c.;and PROPN iajs-53 152 4 ikewuchi ikewuchi PROPN iajs-53 152 5 , , PUNCT iajs-53 152 6 c. c. PROPN iajs-53 152 7 ( ( PUNCT iajs-53 152 8 2009 2009 NUM iajs-53 152 9 ) ) PUNCT iajs-53 152 10 . . PUNCT iajs-53 153 1 alteration alteration NOUN iajs-53 153 2 of of ADP iajs-53 153 3 plasma plasma NOUN iajs-53 153 4 lipid lipid NOUN iajs-53 153 5 profile profile NOUN iajs-53 153 6 and and CCONJ iajs-53 153 7 atherogenic atherogenic ADJ iajs-53 153 8 indices index NOUN iajs-53 153 9 of of ADP iajs-53 153 10 cholesterol cholesterol NOUN iajs-53 153 11 loaded load VERB iajs-53 153 12 rats rat NOUN iajs-53 153 13 implication implication NOUN iajs-53 153 14 for for ADP iajs-53 153 15 the the DET iajs-53 153 16 management management NOUN iajs-53 153 17 of of ADP iajs-53 153 18 obesity obesity NOUN iajs-53 153 19 and and CCONJ iajs-53 153 20 cardiovascular cardiovascular ADJ iajs-53 153 21 disease disease NOUN iajs-53 153 22 . . PUNCT iajs-53 154 1 biochemistry biochemistry NOUN iajs-53 154 2 ; ; PUNCT iajs-53 154 3 21(2):96 21(2):96 NUM iajs-53 154 4 - - SYM iajs-53 154 5 102 102 NUM iajs-53 154 6 . . PUNCT iajs-53 155 1 18 18 NUM iajs-53 155 2 . . X iajs-53 156 1 ann ann PROPN iajs-53 156 2 , , PUNCT iajs-53 156 3 c c PROPN iajs-53 156 4 . . PUNCT iajs-53 156 5 ; ; PUNCT iajs-53 156 6 lucy lucy PROPN iajs-53 156 7 , , PUNCT iajs-53 156 8 c. c. PROPN iajs-53 156 9 ; ; PUNCT iajs-53 156 10 and and CCONJ iajs-53 156 11 jones jones PROPN iajs-53 156 12 et et PROPN iajs-53 156 13 al al PROPN iajs-53 156 14 . . PROPN iajs-53 156 15 ( ( PUNCT iajs-53 156 16 2001 2001 NUM iajs-53 156 17 ) ) PUNCT iajs-53 156 18 . . PUNCT iajs-53 156 19 decreased decrease VERB iajs-53 156 20 insulin insulin NOUN iajs-53 156 21 secretion secretion NOUN iajs-53 156 22 in in ADP iajs-53 156 23 type2 type2 PROPN iajs-53 156 24 diabetes diabetes NOUN iajs-53 156 25 problem problem NOUN iajs-53 156 26 of of ADP iajs-53 156 27 cellular cellular ADJ iajs-53 156 28 mass mass NOUN iajs-53 156 29 or or CCONJ iajs-53 156 30 function function NOUN iajs-53 156 31 ? ? PUNCT iajs-53 156 32 . . PUNCT iajs-53 157 1 diabetes diabetes NOUN iajs-53 157 2 ; ; PUNCT iajs-53 157 3 50 50 NUM iajs-53 157 4 : : PUNCT iajs-53 157 5 suppl suppl PROPN iajs-53 157 6 i. i. PROPN iajs-53 157 7 19.cook 19.cook PROPN iajs-53 157 8 , , PUNCT iajs-53 157 9 cb cb PROPN iajs-53 157 10 . . PROPN iajs-53 157 11 ; ; PUNCT iajs-53 157 12 erdman erdman PROPN iajs-53 157 13 , , PUNCT iajs-53 157 14 dm dm PROPN iajs-53 157 15 . . PUNCT iajs-53 157 16 ; ; PUNCT iajs-53 157 17 ruyan ruyan PROPN iajs-53 157 18 , , PUNCT iajs-53 157 19 gj gj PROPN iajs-53 157 20 . . PUNCT iajs-53 157 21 ; ; PUNCT iajs-53 157 22 greenland greenland PROPN iajs-53 157 23 , , PUNCT iajs-53 157 24 kj kj PROPN iajs-53 157 25 . . PUNCT iajs-53 157 26 ; ; PUNCT iajs-53 158 1 giles gile NOUN iajs-53 158 2 , , PUNCT iajs-53 158 3 wh.;and wh.;and PROPN iajs-53 158 4 galina galina PROPN iajs-53 158 5 , , PUNCT iajs-53 158 6 dl dl PROPN iajs-53 158 7 . . PUNCT iajs-53 158 8 ( ( PUNCT iajs-53 158 9 2000 2000 NUM iajs-53 158 10 ) ) PUNCT iajs-53 158 11 . . PUNCT iajs-53 159 1 diabetes diabetes NOUN iajs-53 159 2 care care VERB iajs-53 159 3 ; ; PUNCT iajs-53 159 4 23:319 23:319 NUM iajs-53 159 5 - - SYM iajs-53 159 6 321 321 NUM iajs-53 159 7 . . PUNCT iajs-53 160 1 20.okafo 20.okafo NUM iajs-53 160 2 , , PUNCT iajs-53 160 3 ci ci PROPN iajs-53 160 4 . . PROPN iajs-53 160 5 ; ; PUNCT iajs-53 160 6 fasanmade fasanmade VERB iajs-53 160 7 , , PUNCT iajs-53 160 8 oa.;and oa.;and NUM iajs-53 160 9 oke oke NOUN iajs-53 160 10 , , PUNCT iajs-53 160 11 da da PROPN iajs-53 160 12 . . PUNCT iajs-53 161 1 ( ( PUNCT iajs-53 161 2 2008)pattern 2008)pattern NUM iajs-53 161 3 of of ADP iajs-53 161 4 dyslipidemia dyslipidemia NOUN iajs-53 161 5 among among ADP iajs-53 161 6 nigerians nigerians PROPN iajs-53 161 7 with with ADP iajs-53 161 8 type2 type2 PROPN iajs-53 161 9 diabetes diabetes NOUN iajs-53 161 10 mellitus mellitus NOUN iajs-53 161 11 . . PUNCT iajs-53 162 1 niger niger PROPN iajs-53 162 2 j j PROPN iajs-53 162 3 clin clin PROPN iajs-53 162 4 . . PUNCT iajs-53 163 1 pract pract PROPN iajs-53 163 2 ; ; PUNCT iajs-53 163 3 11(1):25 11(1):25 NUM iajs-53 163 4 - - SYM iajs-53 163 5 31 31 NUM iajs-53 163 6 . . PUNCT iajs-53 164 1 21.hawared 21.hawared NUM iajs-53 164 2 , , PUNCT iajs-53 164 3 bv bv PROPN iajs-53 164 4 . . PROPN iajs-53 164 5 ( ( PUNCT iajs-53 164 6 1999 1999 NUM iajs-53 164 7 ) ) PUNCT iajs-53 164 8 . . PUNCT iajs-53 165 1 insulin insulin NOUN iajs-53 165 2 resistance resistance NOUN iajs-53 165 3 and and CCONJ iajs-53 165 4 lipid lipid NOUN iajs-53 165 5 metabolism metabolism NOUN iajs-53 165 6 . . PUNCT iajs-53 166 1 am.j am.j PROPN iajs-53 166 2 . . PUNCT iajs-53 167 1 cardiol cardiol NOUN iajs-53 167 2 ; ; PUNCT iajs-53 167 3 84(1a):28j-31j 84(1a):28j-31j NUM iajs-53 167 4 . . NOUN iajs-53 167 5 22 22 NUM iajs-53 167 6 . . PUNCT iajs-53 168 1 harvy harvy PROPN iajs-53 168 2 , , PUNCT iajs-53 168 3 ra.;and ra.;and NOUN iajs-53 168 4 ferrier ferrier NOUN iajs-53 168 5 , , PUNCT iajs-53 168 6 dr.(2014)lippincott dr.(2014)lippincott PROPN iajs-53 168 7 's 's PART iajs-53 168 8 illustrated illustrate VERB iajs-53 168 9 revews revew NOUN iajs-53 168 10 biochemistry biochemistry NOUN iajs-53 168 11 6thed 6the VERB iajs-53 168 12 . . PUNCT iajs-53 169 1 lippincott lippincott PROPN iajs-53 169 2 williams williams PROPN iajs-53 169 3 and and CCONJ iajs-53 169 4 wilkins wilkin NOUN iajs-53 169 5 : : PUNCT iajs-53 169 6 wolters wolters PROPN iajs-53 169 7 ktuwer ktuwer PROPN iajs-53 169 8 health health PROPN iajs-53 169 9 . . PUNCT iajs-53 170 1 23.hermans 23.herman NOUN iajs-53 170 2 , , PUNCT iajs-53 170 3 m. m. NOUN iajs-53 170 4 ; ; PUNCT iajs-53 170 5 ahn ahn PROPN iajs-53 170 6 , , PUNCT iajs-53 170 7 sa&rousseau sa&rousseau PROPN iajs-53 170 8 , , PUNCT iajs-53 170 9 mf mf X iajs-53 170 10 . . PROPN iajs-53 170 11 ( ( PUNCT iajs-53 170 12 2010 2010 NUM iajs-53 170 13 ) ) PUNCT iajs-53 170 14 . . PUNCT iajs-53 171 1 log(tg log(tg PROPN iajs-53 171 2 / / SYM iajs-53 171 3 hdl hdl PROPN iajs-53 171 4 - - PUNCT iajs-53 171 5 c c NOUN iajs-53 171 6 ) ) PUNCT iajs-53 171 7 is be AUX iajs-53 171 8 related relate VERB iajs-53 171 9 to to ADP iajs-53 171 10 both both PRON iajs-53 171 11 residual residual ADJ iajs-53 171 12 cardiometabolic cardiometabolic NOUN iajs-53 171 13 risk risk NOUN iajs-53 171 14 and and CCONJ iajs-53 171 15 β β NOUN iajs-53 171 16 - - NOUN iajs-53 171 17 cell cell NOUN iajs-53 171 18 function function NOUN iajs-53 171 19 loss loss NOUN iajs-53 171 20 in in ADP iajs-53 171 21 type2 type2 PROPN iajs-53 171 22 diabetes diabetes NOUN iajs-53 171 23 mellitus mellitus PROPN iajs-53 171 24 .j .j PROPN iajs-53 171 25 .cardiovascular .cardiovascular CCONJ iajs-53 171 26 diabetology diabetology NOUN iajs-53 171 27 ; ; PUNCT iajs-53 171 28 9(88):1 9(88):1 X iajs-53 171 29 - - SYM iajs-53 171 30 10 10 NUM iajs-53 171 31 . . PUNCT iajs-53 172 1 24.rajab 24.rajab NUM iajs-53 172 2 , , PUNCT iajs-53 172 3 tm tm PROPN iajs-53 172 4 . . PROPN iajs-53 172 5 ( ( PUNCT iajs-53 172 6 2012 2012 NUM iajs-53 172 7 ) ) PUNCT iajs-53 172 8 . . PUNCT iajs-53 173 1 comparative comparative ADJ iajs-53 173 2 study study NOUN iajs-53 173 3 for for ADP iajs-53 173 4 atherogenic atherogenic ADJ iajs-53 173 5 index index NOUN iajs-53 173 6 of of ADP iajs-53 173 7 plasma plasma NOUN iajs-53 173 8 aip aip PROPN iajs-53 173 9 in in ADP iajs-53 173 10 patient patient NOUN iajs-53 173 11 with with ADP iajs-53 173 12 type1 type1 NOUN iajs-53 173 13 diabetes diabetes NOUN iajs-53 173 14 mellitus mellitus NOUN iajs-53 173 15 , , PUNCT iajs-53 173 16 type2diabetes type2diabete VERB iajs-53 173 17 mellitus mellitus NOUN iajs-53 173 18 , , PUNCT iajs-53 173 19 betathalassemia betathalassemia NOUN iajs-53 173 20 and and CCONJ iajs-53 173 21 hypothyroidism hypothyroidism NOUN iajs-53 173 22 . . PUNCT iajs-53 174 1 inter inter PROPN iajs-53 174 2 . . PUNCT iajs-53 175 1 j. j. PROPN iajs-53 175 2 chem chem PROPN iajs-53 175 3 . . PUNCT iajs-53 176 1 res re NOUN iajs-53 176 2 ; ; PUNCT iajs-53 176 3 2(2):1 2(2):1 NOUN iajs-53 176 4 - - SYM iajs-53 176 5 9 9 NUM iajs-53 176 6 . . PUNCT iajs-53 177 1 25.kalidhas 25.kalidhas X iajs-53 177 2 , , PUNCT iajs-53 177 3 p. p. NOUN iajs-53 177 4 ; ; PUNCT iajs-53 177 5 kanniappan kanniappan PROPN iajs-53 177 6 , , PUNCT iajs-53 177 7 d. d. PROPN iajs-53 177 8 ; ; PUNCT iajs-53 177 9 gandi gandi PROPN iajs-53 177 10 , , PUNCT iajs-53 177 11 k.;and k.;and NOUN iajs-53 177 12 aruna aruna PROPN iajs-53 177 13 , , PUNCT iajs-53 177 14 r. r. PROPN iajs-53 177 15 ( ( PUNCT iajs-53 177 16 2011 2011 NUM iajs-53 177 17 ) ) PUNCT iajs-53 177 18 . . PUNCT iajs-53 178 1 coronary coronary ADJ iajs-53 178 2 artery artery NOUN iajs-53 178 3 disease disease NOUN iajs-53 178 4 risk risk NOUN iajs-53 178 5 factor factor NOUN iajs-53 178 6 in in ADP iajs-53 178 7 type2 type2 PROPN iajs-53 178 8 diabetes diabetes NOUN iajs-53 178 9 mellitus mellitus NOUN iajs-53 178 10 with with ADP iajs-53 178 11 metabolic metabolic NOUN iajs-53 178 12 syndrome syndrome NOUN iajs-53 178 13 in in ADP iajs-53 178 14 the the DET iajs-53 178 15 urban urban ADJ iajs-53 178 16 south south PROPN iajs-53 178 17 indian indian ADJ iajs-53 178 18 population population NOUN iajs-53 178 19 . . PUNCT iajs-53 179 1 clinical clinical ADJ iajs-53 179 2 and and CCONJ iajs-53 179 3 diagnostic diagnostic ADJ iajs-53 179 4 research research NOUN iajs-53 179 5 .j .j NOUN iajs-53 179 6 ; ; PUNCT iajs-53 180 1 5(3):516 5(3):516 NUM iajs-53 180 2 - - SYM iajs-53 180 3 518 518 NUM iajs-53 180 4 . . NOUN iajs-53 180 5 26 26 NUM iajs-53 180 6 . . PUNCT iajs-53 180 7 njajou njajou PROPN iajs-53 180 8 , , PUNCT iajs-53 180 9 o. o. PROPN iajs-53 180 10 ; ; PUNCT iajs-53 180 11 kanaya kanaya PROPN iajs-53 180 12 , , PUNCT iajs-53 180 13 am be AUX iajs-53 180 14 . . PUNCT iajs-53 180 15 ; ; PUNCT iajs-53 180 16 holvoet holvoet VERB iajs-53 180 17 , , PUNCT iajs-53 180 18 p. p. PROPN iajs-53 180 19 ; ; PUNCT iajs-53 181 1 connelly connelly PROPN iajs-53 181 2 , , PUNCT iajs-53 181 3 s s PROPN iajs-53 181 4 & & CCONJ iajs-53 181 5 harris harris PROPN iajs-53 181 6 , , PUNCT iajs-53 181 7 t. t. PROPN iajs-53 181 8 ( ( PUNCT iajs-53 181 9 2009 2009 NUM iajs-53 181 10 ) ) PUNCT iajs-53 181 11 . . PUNCT iajs-53 182 1 association association NOUN iajs-53 182 2 between between ADP iajs-53 182 3 oxidized oxidize VERB iajs-53 182 4 ldl ldl NOUN iajs-53 182 5 - - PUNCT iajs-53 182 6 c c NOUN iajs-53 182 7 obesity obesity NOUN iajs-53 182 8 and and CCONJ iajs-53 182 9 type2 type2 NOUN iajs-53 182 10 diabetes diabetes NOUN iajs-53 182 11 . . PUNCT iajs-53 183 1 diabetes diabetes NOUN iajs-53 183 2 . . PUNCT iajs-53 184 1 meta meta X iajs-53 184 2 . . PUNCT iajs-53 185 1 res re NOUN iajs-53 185 2 . . PUNCT iajs-53 186 1 rev rev PROPN iajs-53 186 2 ; ; PUNCT iajs-53 186 3 25(8):733 25(8):733 NUM iajs-53 186 4 - - SYM iajs-53 186 5 9 9 NUM iajs-53 186 6 . . NUM iajs-53 187 1 27.ezzat 27.ezzat NUM iajs-53 187 2 , , PUNCT iajs-53 187 3 va va NOUN iajs-53 187 4 . . PROPN iajs-53 187 5 ; ; PUNCT iajs-53 188 1 duncan duncan PROPN iajs-53 188 2 , , PUNCT iajs-53 188 3 er er INTJ iajs-53 188 4 . . PUNCT iajs-53 188 5 ; ; PUNCT iajs-53 188 6 wheatcroft wheatcroft PROPN iajs-53 188 7 , , PUNCT iajs-53 188 8 sb&kearney sb&kearney PROPN iajs-53 188 9 , , PUNCT iajs-53 188 10 mt mt PROPN iajs-53 188 11 . . PROPN iajs-53 188 12 ( ( PUNCT iajs-53 188 13 2008 2008 NUM iajs-53 188 14 ) ) PUNCT iajs-53 188 15 . . PUNCT iajs-53 189 1 the the DET iajs-53 189 2 role role NOUN iajs-53 189 3 of of ADP iajs-53 189 4 igf-1 igf-1 NOUN iajs-53 189 5 and and CCONJ iajs-53 189 6 binding bind VERB iajs-53 189 7 protein protein NOUN iajs-53 189 8 in in ADP iajs-53 189 9 the the DET iajs-53 189 10 development development NOUN iajs-53 189 11 of of ADP iajs-53 189 12 type2 type2 PROPN iajs-53 189 13 diabetes diabetes NOUN iajs-53 189 14 and and CCONJ iajs-53 189 15 cardiovascular cardiovascular ADJ iajs-53 189 16 disease disease NOUN iajs-53 189 17 . . PUNCT iajs-53 190 1 diabetes diabetes NOUN iajs-53 190 2 .obs.meta .obs.meta PROPN iajs-53 190 3 ; ; PUNCT iajs-53 190 4 10(3):198 10(3):198 NUM iajs-53 190 5 - - SYM iajs-53 190 6 211 211 NUM iajs-53 190 7 . . PUNCT iajs-53 191 1 130 130 NUM iajs-53 191 2 | | ADV iajs-53 191 3 chemistry chemistry NOUN iajs-53 191 4 2016عام 2016عام NOUN iajs-53 191 5 ) ) PUNCT iajs-53 192 1 1(العدد 1(العدد NUM iajs-53 192 2 29لمجلد 29لمجلد NUM iajs-53 193 1 ا ا X iajs-53 194 1 مجلة مجلة ADJ iajs-53 194 2 إبن إبن VERB iajs-53 194 3 الهيثم الهيثم ADJ iajs-53 194 4 للعلوم للعلوم NOUN iajs-53 194 5 الصرفة الصرفة NOUN iajs-53 195 1 و و PRON iajs-53 195 2 التطبيقية التطبيقية ADJ iajs-53 195 3 ibn ibn PROPN iajs-53 195 4 al al PROPN iajs-53 195 5 - - PUNCT iajs-53 195 6 haitham haitham PROPN iajs-53 195 7 jour jour X iajs-53 195 8 . . PROPN iajs-53 195 9 for for ADP iajs-53 195 10 pure pure ADJ iajs-53 195 11 & & CCONJ iajs-53 195 12 appl appl PROPN iajs-53 195 13 . . PUNCT iajs-53 196 1 sci sci PROPN iajs-53 196 2 . . PUNCT iajs-53 196 3 vol vol NOUN iajs-53 196 4 . . PROPN iajs-53 196 5 29 29 NUM iajs-53 196 6 ( ( PUNCT iajs-53 196 7 1 1 NUM iajs-53 196 8 ) ) PUNCT iajs-53 196 9 2016 2016 NUM iajs-53 197 1 28.conti 28.conti NUM iajs-53 197 2 , , PUNCT iajs-53 197 3 e e X iajs-53 197 4 . . PUNCT iajs-53 197 5 ; ; PUNCT iajs-53 197 6 carrozza carrozza PROPN iajs-53 197 7 , , PUNCT iajs-53 197 8 c. c. PROPN iajs-53 197 9 ; ; PUNCT iajs-53 197 10 capoluongo capoluongo PROPN iajs-53 197 11 , , PUNCT iajs-53 197 12 e. e. PROPN iajs-53 197 13 ; ; PUNCT iajs-53 197 14 volp volp PROPN iajs-53 197 15 , , PUNCT iajs-53 197 16 m. m. NOUN iajs-53 197 17 ; ; PUNCT iajs-53 197 18 crea crea PROPN iajs-53 197 19 , , PUNCT iajs-53 197 20 f. f. PROPN iajs-53 197 21 ; ; PUNCT iajs-53 197 22 andreotti andreotti PROPN iajs-53 197 23 , , PUNCT iajs-53 197 24 f f PROPN iajs-53 197 25 & & CCONJ iajs-53 197 26 zuppi zuppi PROPN iajs-53 197 27 , , PUNCT iajs-53 197 28 c. c. PROPN iajs-53 197 29 ( ( PUNCT iajs-53 197 30 2004 2004 NUM iajs-53 197 31 ) ) PUNCT iajs-53 197 32 . . PUNCT iajs-53 198 1 insulin insulin NOUN iajs-53 198 2 like like ADP iajs-53 198 3 growth growth NOUN iajs-53 198 4 factor-1 factor-1 PROPN iajs-53 198 5 as as ADP iajs-53 198 6 avascular avascular ADJ iajs-53 198 7 protective protective ADJ iajs-53 198 8 factor factor NOUN iajs-53 198 9 . . PUNCT iajs-53 199 1 circulation circulation NOUN iajs-53 199 2 ; ; PUNCT iajs-53 199 3 110:22602265 110:22602265 X iajs-53 199 4 . . X iajs-53 199 5 29 29 NUM iajs-53 199 6 . . PUNCT iajs-53 200 1 hasan hasan PROPN iajs-53 200 2 , , PUNCT iajs-53 200 3 bf bf PROPN iajs-53 200 4 . . PROPN iajs-53 200 5 ; ; PUNCT iajs-53 200 6 salman salman PROPN iajs-53 200 7 , , PUNCT iajs-53 200 8 in in ADP iajs-53 200 9 & & CCONJ iajs-53 200 10 hamza hamza PROPN iajs-53 200 11 , , PUNCT iajs-53 200 12 na na NOUN iajs-53 200 13 . . PUNCT iajs-53 200 14 ( ( PUNCT iajs-53 200 15 2012 2012 NUM iajs-53 200 16 ) ) PUNCT iajs-53 200 17 . . PUNCT iajs-53 201 1 the the DET iajs-53 201 2 relation relation NOUN iajs-53 201 3 of of ADP iajs-53 201 4 igf-1 igf-1 NOUN iajs-53 201 5 and and CCONJ iajs-53 201 6 insulin insulin NOUN iajs-53 201 7 resistance resistance NOUN iajs-53 201 8 in in ADP iajs-53 201 9 a a DET iajs-53 201 10 sample sample NOUN iajs-53 201 11 of of ADP iajs-53 201 12 iraqi iraqi ADJ iajs-53 201 13 obese obese PROPN iajs-53 201 14 type2 type2 PROPN iajs-53 201 15 diabetic diabetic ADJ iajs-53 201 16 patients patient NOUN iajs-53 201 17 with with ADP iajs-53 201 18 macrovascular macrovascular ADJ iajs-53 201 19 disease disease NOUN iajs-53 201 20 . . PUNCT iajs-53 202 1 j j PROPN iajs-53 202 2 . . PUNCT iajs-53 203 1 bad.sci bad.sci PROPN iajs-53 203 2 ; ; PUNCT iajs-53 203 3 9(4):656 9(4):656 NUM iajs-53 203 4 - - SYM iajs-53 203 5 662 662 NUM iajs-53 203 6 . . PUNCT iajs-53 204 1 30.li 30.li NUM iajs-53 204 2 , , PUNCT iajs-53 204 3 q. q. PROPN iajs-53 204 4 ; ; PUNCT iajs-53 204 5 yin yin PROPN iajs-53 204 6 , , PUNCT iajs-53 204 7 w. w. PROPN iajs-53 204 8 ; ; PUNCT iajs-53 204 9 cai cai PROPN iajs-53 204 10 , , PUNCT iajs-53 204 11 m. m. NOUN iajs-53 204 12 ; ; PUNCT iajs-53 204 13 lin lin PROPN iajs-53 204 14 , , PUNCT iajs-53 204 15 y. y. PROPN iajs-53 204 16 ; ; PUNCT iajs-53 204 17 hou hou PROPN iajs-53 204 18 , , PUNCT iajs-53 204 19 h. h. PROPN iajs-53 204 20 ; ; PUNCT iajs-53 204 21 shen shen PROPN iajs-53 204 22 , , PUNCT iajs-53 204 23 q. q. PROPN iajs-53 204 24 ; ; PUNCT iajs-53 204 25 zhang zhang PROPN iajs-53 204 26 , , PUNCT iajs-53 204 27 c. c. PROPN iajs-53 204 28 ; ; PUNCT iajs-53 204 29 xiao xiao PROPN iajs-53 204 30 , , PUNCT iajs-53 204 31 j. j. PROPN iajs-53 204 32 ; ; PUNCT iajs-53 204 33 hux hux PROPN iajs-53 204 34 . . PROPN iajs-53 204 35 ; ; PUNCT iajs-53 204 36 wuq wuq PROPN iajs-53 204 37 . . PROPN iajs-53 204 38 ; ; PUNCT iajs-53 204 39 funak funak PROPN iajs-53 204 40 , , PUNCT iajs-53 204 41 m. m. NOUN iajs-53 204 42 ; ; PUNCT iajs-53 204 43 and and CCONJ iajs-53 204 44 nakaya nakaya PROPN iajs-53 204 45 , , PUNCT iajs-53 204 46 y. y. PROPN iajs-53 204 47 ( ( PUNCT iajs-53 204 48 2010 2010 NUM iajs-53 204 49 ) ) PUNCT iajs-53 204 50 . . PUNCT iajs-53 205 1 no-1886 no-1886 PROPN iajs-53 205 2 suppresses suppress VERB iajs-53 205 3 diet diet NOUN iajs-53 205 4 induced induce VERB iajs-53 205 5 insulin insulin NOUN iajs-53 205 6 resistance resistance NOUN iajs-53 205 7 and and CCONJ iajs-53 205 8 cholesterol cholesterol NOUN iajs-53 205 9 accumulation accumulation NOUN iajs-53 205 10 through through ADP iajs-53 205 11 stats stat NOUN iajs-53 205 12 - - PUNCT iajs-53 205 13 dependent dependent ADJ iajs-53 205 14 upregulation upregulation NOUN iajs-53 205 15 of of ADP iajs-53 205 16 igf-1 igf-1 NOUN iajs-53 205 17 and and CCONJ iajs-53 205 18 cyp7ai cyp7ai NUM iajs-53 205 19 . . PUNCT iajs-53 206 1 jou jou PROPN iajs-53 206 2 . . PROPN iajs-53 206 3 of of ADP iajs-53 206 4 . . PUNCT iajs-53 207 1 endocrinology endocrinology NOUN iajs-53 207 2 ; ; PUNCT iajs-53 207 3 204:47 204:47 PROPN iajs-53 207 4 - - SYM iajs-53 207 5 56 56 NUM iajs-53 207 6 . . PUNCT iajs-53 208 1 31.yakar 31.yakar NUM iajs-53 208 2 , , PUNCT iajs-53 208 3 s. s. PROPN iajs-53 208 4 ; ; PUNCT iajs-53 208 5 liu liu PROPN iajs-53 208 6 , , PUNCT iajs-53 208 7 jl.;,fernandez jl.;,fernandez PROPN iajs-53 208 8 , , PUNCT iajs-53 208 9 am be AUX iajs-53 208 10 . . PUNCT iajs-53 208 11 ; ; PUNCT iajs-53 209 1 wu wu PROPN iajs-53 209 2 , , PUNCT iajs-53 209 3 y. y. PROPN iajs-53 209 4 ; ; PUNCT iajs-53 209 5 schally schally ADV iajs-53 209 6 , , PUNCT iajs-53 209 7 av av PROPN iajs-53 209 8 . . PUNCT iajs-53 209 9 ; ; PUNCT iajs-53 209 10 frystyk frystyk NOUN iajs-53 209 11 , , PUNCT iajs-53 209 12 j. j. PROPN iajs-53 209 13 ; ; PUNCT iajs-53 209 14 chernausch chernausch NOUN iajs-53 209 15 , , PUNCT iajs-53 209 16 sd sd NOUN iajs-53 209 17 . . PUNCT iajs-53 209 18 ; ; PUNCT iajs-53 209 19 mejia mejia PROPN iajs-53 209 20 , , PUNCT iajs-53 209 21 w&le w&le PROPN iajs-53 209 22 . . PUNCT iajs-53 209 23 ; ; PUNCT iajs-53 209 24 roith roith PROPN iajs-53 209 25 , , PUNCT iajs-53 209 26 d. d. PROPN iajs-53 209 27 ( ( PUNCT iajs-53 209 28 2001 2001 NUM iajs-53 209 29 ) ) PUNCT iajs-53 209 30 . . PUNCT iajs-53 210 1 lever lever ADJ iajs-53 210 2 – – PUNCT iajs-53 210 3 specific specific ADJ iajs-53 210 4 igf igf NOUN iajs-53 210 5 - - ADJ iajs-53 210 6 gene gene NOUN iajs-53 210 7 deletion deletion NOUN iajs-53 210 8 leeds leed NOUN iajs-53 210 9 to to PART iajs-53 210 10 muscle muscle VERB iajs-53 210 11 insulin insulin NOUN iajs-53 210 12 insensitivity insensitivity NOUN iajs-53 210 13 . . PUNCT iajs-53 211 1 diabetes diabetes NOUN iajs-53 211 2 ; ; PUNCT iajs-53 211 3 50:1110 50:1110 NUM iajs-53 211 4 - - SYM iajs-53 211 5 1118 1118 NUM iajs-53 211 6 . . PUNCT iajs-53 212 1 table table NOUN iajs-53 212 2 ( ( PUNCT iajs-53 212 3 1 1 NUM iajs-53 212 4 ): ): PUNCT iajs-53 212 5 descriptive descriptive ADJ iajs-53 212 6 parameters parameter NOUN iajs-53 212 7 of of ADP iajs-53 212 8 the the DET iajs-53 212 9 studied study VERB iajs-53 212 10 groups group NOUN iajs-53 212 11 . . PUNCT iajs-53 213 1 3&g2 3&g2 NUM iajs-53 213 2 g g PROPN iajs-53 213 3 t. t. PROPN iajs-53 213 4 test test NOUN iajs-53 213 5 3&g1 3&g1 NUM iajs-53 213 6 g g PROPN iajs-53 213 7 t. t. PROPN iajs-53 213 8 test test NOUN iajs-53 213 9 2&g1 2&g1 NUM iajs-53 213 10 g g ADP iajs-53 213 11 t. t. NOUN iajs-53 213 12 test test NOUN iajs-53 213 13 3 3 NUM iajs-53 213 14 g g NOUN iajs-53 213 15 mean mean NOUN iajs-53 213 16 ± ± NUM iajs-53 213 17 sem sem NOUN iajs-53 213 18 2 2 NUM iajs-53 213 19 g g NOUN iajs-53 213 20 mean mean NOUN iajs-53 213 21 ± ± NUM iajs-53 213 22 sem sem NOUN iajs-53 213 23 1 1 NUM iajs-53 213 24 g g NOUN iajs-53 213 25 mean mean NOUN iajs-53 213 26 ± ± NUM iajs-53 213 27 sem sem NOUN iajs-53 213 28 groups group NOUN iajs-53 213 29 parameters parameter NOUN iajs-53 213 30     SPACE iajs-53 213 31 male male NOUN iajs-53 213 32 ( ( PUNCT iajs-53 213 33 9 9 NUM iajs-53 213 34 ) ) PUNCT iajs-53 213 35 female female NOUN iajs-53 213 36 ( ( PUNCT iajs-53 213 37 11 11 NUM iajs-53 213 38 ) ) PUNCT iajs-53 213 39 male(11 male(11 NUM iajs-53 213 40 ) ) PUNCT iajs-53 213 41 female female NOUN iajs-53 213 42 ( ( PUNCT iajs-53 213 43 9 9 NUM iajs-53 213 44 ) ) PUNCT iajs-53 213 45 male male NOUN iajs-53 213 46 ( ( PUNCT iajs-53 213 47 10 10 NUM iajs-53 213 48 ) ) PUNCT iajs-53 213 49 female female NOUN iajs-53 213 50 ( ( PUNCT iajs-53 213 51 10 10 NUM iajs-53 213 52 ) ) PUNCT iajs-53 213 53 subject.no subject.no PROPN iajs-53 214 1 ns ns NUM iajs-53 214 2 s s NOUN iajs-53 214 3 s s PROPN iajs-53 215 1 201.75±15.14 201.75±15.14 NUM iajs-53 215 2 167.45±7.66 167.45±7.66 NUM iajs-53 215 3 86.5±2.06 86.5±2.06 NUM iajs-53 215 4 fbs(mg fbs(mg PROPN iajs-53 215 5 / / SYM iajs-53 215 6 dl dl NOUN iajs-53 215 7 ) ) PUNCT iajs-53 215 8 ns ns PROPN iajs-53 215 9 s s PROPN iajs-53 215 10 s s PART iajs-53 215 11 8.40±0.42 8.40±0.42 NUM iajs-53 215 12 7.84±0.22 7.84±0.22 NUM iajs-53 215 13 5.74±0.09 5.74±0.09 NUM iajs-53 215 14 hba1c hba1c PROPN iajs-53 215 15 ( ( PUNCT iajs-53 215 16 % % NOUN iajs-53 215 17 ) ) PUNCT iajs-53 215 18 131 131 NUM iajs-53 215 19 | | ADV iajs-53 215 20 chemistry chemistry NOUN iajs-53 215 21 2016عام 2016عام NOUN iajs-53 215 22 ) ) PUNCT iajs-53 216 1 1(العدد 1(العدد NUM iajs-53 216 2 29لمجلد 29لمجلد NUM iajs-53 217 1 ا ا X iajs-53 218 1 مجلة مجلة ADJ iajs-53 218 2 إبن إبن VERB iajs-53 218 3 الهيثم الهيثم ADJ iajs-53 218 4 للعلوم للعلوم NOUN iajs-53 218 5 الصرفة الصرفة NOUN iajs-53 219 1 و و PRON iajs-53 219 2 التطبيقية التطبيقية ADJ iajs-53 219 3 ibn ibn PROPN iajs-53 219 4 al al PROPN iajs-53 219 5 - - PUNCT iajs-53 219 6 haitham haitham PROPN iajs-53 219 7 jour jour X iajs-53 219 8 . . PROPN iajs-53 219 9 for for ADP iajs-53 219 10 pure pure ADJ iajs-53 219 11 & & CCONJ iajs-53 219 12 appl appl PROPN iajs-53 219 13 . . PUNCT iajs-53 220 1 sci sci PROPN iajs-53 220 2 . . PUNCT iajs-53 220 3 vol vol NOUN iajs-53 220 4 . . PROPN iajs-53 220 5 29 29 NUM iajs-53 220 6 ( ( PUNCT iajs-53 220 7 1 1 NUM iajs-53 220 8 ) ) SYM iajs-53 220 9 2016 2016 NUM iajs-53 220 10 table table NOUN iajs-53 220 11 ( ( PUNCT iajs-53 220 12 2 2 NUM iajs-53 220 13 ): ): PUNCT iajs-53 220 14 levels level NOUN iajs-53 220 15 of of ADP iajs-53 220 16 lipid lipid NOUN iajs-53 220 17 profile profile NOUN iajs-53 220 18 and and CCONJ iajs-53 220 19 aip aip PROPN iajs-53 220 20 in in ADP iajs-53 220 21 all all DET iajs-53 220 22 studied studied ADJ iajs-53 220 23 groups group NOUN iajs-53 220 24 . . PUNCT iajs-53 221 1 table table NOUN iajs-53 221 2 ( ( PUNCT iajs-53 221 3 3 3 NUM iajs-53 221 4 ): ): PUNCT iajs-53 221 5 levels level NOUN iajs-53 221 6 of of ADP iajs-53 221 7 igf-1 igf-1 NOUN iajs-53 221 8 , , PUNCT iajs-53 221 9 insulin insulin NOUN iajs-53 221 10 , , PUNCT iajs-53 221 11 homa homa NOUN iajs-53 221 12 - - PUNCT iajs-53 221 13 ir ir PROPN iajs-53 221 14 in in ADP iajs-53 221 15 all all DET iajs-53 221 16 studied studied ADJ iajs-53 221 17 groups group NOUN iajs-53 221 18 . . PUNCT iajs-53 222 1 3&g2 3&g2 NUM iajs-53 222 2 g g PROPN iajs-53 222 3 t. t. PROPN iajs-53 222 4 test test NOUN iajs-53 222 5 3&g1 3&g1 NUM iajs-53 222 6 g g PROPN iajs-53 222 7 t. t. PROPN iajs-53 222 8 test test NOUN iajs-53 222 9 2&g1 2&g1 NUM iajs-53 222 10 g g ADP iajs-53 222 11 t. t. NOUN iajs-53 222 12 test test NOUN iajs-53 222 13 3 3 NUM iajs-53 222 14 g g NOUN iajs-53 222 15 mean mean NOUN iajs-53 222 16     SPACE iajs-53 222 17 ± ± NOUN iajs-53 222 18 sem sem NOUN iajs-53 222 19 2 2 NUM iajs-53 222 20 g g NOUN iajs-53 222 21 mean mean NOUN iajs-53 222 22     SPACE iajs-53 222 23 ± ± NOUN iajs-53 222 24 sem sem NOUN iajs-53 222 25 1 1 NUM iajs-53 222 26 g g NOUN iajs-53 222 27 mean mean NOUN iajs-53 222 28 ± ± NUM iajs-53 222 29 sem sem NOUN iajs-53 222 30 groups group NOUN iajs-53 222 31 parameters parameter NOUN iajs-53 222 32 s s PART iajs-53 222 33 s s NOUN iajs-53 222 34 ns ns NUM iajs-53 222 35 192.7±12.35 192.7±12.35 PROPN iajs-53 222 36 169.25±6.47 169.25±6.47 NUM iajs-53 222 37 168.75±4.12 168.75±4.12 NUM iajs-53 222 38 tc tc NUM iajs-53 222 39 ( ( PUNCT iajs-53 222 40 mg mg PROPN iajs-53 222 41 / / SYM iajs-53 222 42 dl dl PROPN iajs-53 222 43 ) ) PUNCT iajs-53 222 44 s s PART iajs-53 222 45 s s NOUN iajs-53 222 46 ns ns NUM iajs-53 222 47 186.75±16.44 186.75±16.44 NUM iajs-53 222 48 138.85±3.11 138.85±3.11 NUM iajs-53 222 49 127.3±3.59 127.3±3.59 NUM iajs-53 222 50 tg tg PROPN iajs-53 222 51 ( ( PUNCT iajs-53 222 52 mg mg PROPN iajs-53 222 53 / / SYM iajs-53 222 54 dl dl NOUN iajs-53 222 55 ) ) PUNCT iajs-53 222 56 ns ns PROPN iajs-53 222 57 s s PROPN iajs-53 222 58 s s PART iajs-53 222 59 44.1±1.80 44.1±1.80 NUM iajs-53 222 60 44.95±1.61 44.95±1.61 NUM iajs-53 222 61 54.65±1.08 54.65±1.08 NUM iajs-53 222 62 hdl hdl PROPN iajs-53 222 63 - - PUNCT iajs-53 222 64 c c PROPN iajs-53 222 65 ( ( PUNCT iajs-53 222 66 mg mg PROPN iajs-53 222 67 / / SYM iajs-53 222 68 dl dl PROPN iajs-53 222 69 ) ) PUNCT iajs-53 222 70 s s PART iajs-53 222 71 s s NOUN iajs-53 222 72 ns ns NUM iajs-53 222 73 113.45±13.77 113.45±13.77 NUM iajs-53 222 74 89.85±6.31 89.85±6.31 NUM iajs-53 222 75 88.75±3.92 88.75±3.92 NUM iajs-53 222 76 ldl ldl PROPN iajs-53 222 77 - - PUNCT iajs-53 222 78 c c PROPN iajs-53 222 79 ( ( PUNCT iajs-53 222 80 mg mg PROPN iajs-53 222 81 / / SYM iajs-53 222 82 dl dl PROPN iajs-53 222 83 ) ) PUNCT iajs-53 222 84 s s PART iajs-53 222 85 s s NOUN iajs-53 222 86 ns ns NUM iajs-53 222 87 36.9±3.32 36.9±3.32 NUM iajs-53 222 88 27.77±0.91 27.77±0.91 NUM iajs-53 222 89 26.15±1.21 26.15±1.21 NUM iajs-53 222 90 vldl vldl NOUN iajs-53 222 91 - - PUNCT iajs-53 222 92 c c NOUN iajs-53 222 93 ( ( PUNCT iajs-53 222 94 mg mg PROPN iajs-53 222 95 / / SYM iajs-53 222 96 dl dl PROPN iajs-53 222 97 ) ) PUNCT iajs-53 222 98 s s PART iajs-53 222 99 s s NOUN iajs-53 222 100 ns ns NUM iajs-53 222 101 0.60±0.04 0.60±0.04 NOUN iajs-53 222 102 0.45±0.02 0.45±0.02 PROPN iajs-53 222 103 0.36±0.02 0.36±0.02 PROPN iajs-53 222 104 aip aip PROPN iajs-53 222 105 3&g2 3&g2 NUM iajs-53 222 106 g g PROPN iajs-53 222 107 t. t. PROPN iajs-53 222 108 test test NOUN iajs-53 223 1 3&g1 3&g1 NUM iajs-53 223 2 g g PROPN iajs-53 223 3 t. t. PROPN iajs-53 223 4 test test NOUN iajs-53 223 5 2&g1 2&g1 NUM iajs-53 223 6 g g ADP iajs-53 223 7 t. t. NOUN iajs-53 223 8 test test NOUN iajs-53 223 9 3 3 NUM iajs-53 223 10 g g NOUN iajs-53 223 11 mean±sem mean±sem PROPN iajs-53 223 12 2 2 NUM iajs-53 223 13 g g NOUN iajs-53 223 14 mean±sem mean±sem NOUN iajs-53 223 15 1 1 NUM iajs-53 223 16 g g NOUN iajs-53 223 17 mean mean NOUN iajs-53 223 18 ± ± NUM iajs-53 223 19 sem sem NOUN iajs-53 223 20 groups group NOUN iajs-53 223 21 parameters parameter NOUN iajs-53 223 22 ns ns NUM iajs-53 223 23 s s NOUN iajs-53 223 24 s s NOUN iajs-53 223 25 116.9±9.19 116.9±9.19 NUM iajs-53 223 26 104.4 104.4 NUM iajs-53 223 27 ±6.77 ±6.77 NOUN iajs-53 223 28 236.45±8.93 236.45±8.93 NUM iajs-53 223 29 igf-1 igf-1 PRON iajs-53 223 30 ( ( PUNCT iajs-53 223 31 ng ng NOUN iajs-53 223 32 / / SYM iajs-53 223 33 ml ml NOUN iajs-53 223 34 ) ) PUNCT iajs-53 223 35 ns ns PRON iajs-53 223 36 s s NOUN iajs-53 223 37 s s NOUN iajs-53 223 38 17.46±1.09 17.46±1.09 PROPN iajs-53 223 39 15.79±1.45 15.79±1.45 NUM iajs-53 223 40 2.32±1.11 2.32±1.11 ADJ iajs-53 223 41 insulin insulin NOUN iajs-53 223 42 level level NOUN iajs-53 223 43 ( ( PUNCT iajs-53 223 44 ng ng NOUN iajs-53 223 45 / / SYM iajs-53 223 46 ml ml NOUN iajs-53 223 47 ) ) PUNCT iajs-53 223 48 ns ns NUM iajs-53 223 49 s s NOUN iajs-53 223 50 s s PART iajs-53 223 51 8.58±0.75 8.58±0.75 NOUN iajs-53 223 52 6.67±0.70 6.67±0.70 NUM iajs-53 223 53 2.7±0.28 2.7±0.28 NUM iajs-53 223 54 homa homa NOUN iajs-53 223 55 - - PUNCT iajs-53 223 56 ir ir PROPN iajs-53 223 57 132 132 NUM iajs-53 223 58 | | NOUN iajs-53 223 59 chemistry chemistry NOUN iajs-53 223 60 2016عام 2016عام NOUN iajs-53 223 61 ) ) PUNCT iajs-53 223 62 1(العدد 1(العدد NUM iajs-53 223 63 29لمجلد 29لمجلد NUM iajs-53 223 64 ا ا X iajs-53 224 1 مجلة مجلة ADJ iajs-53 224 2 إبن إبن VERB iajs-53 224 3 الهيثم الهيثم ADJ iajs-53 224 4 للعلوم للعلوم NOUN iajs-53 224 5 الصرفة الصرفة NOUN iajs-53 225 1 و و PRON iajs-53 225 2 التطبيقية التطبيقية ADJ iajs-53 225 3 ibn ibn PROPN iajs-53 225 4 al al PROPN iajs-53 225 5 - - PUNCT iajs-53 225 6 haitham haitham PROPN iajs-53 225 7 jour jour X iajs-53 225 8 . . PROPN iajs-53 225 9 for for ADP iajs-53 225 10 pure pure ADJ iajs-53 225 11 & & CCONJ iajs-53 225 12 appl appl PROPN iajs-53 225 13 . . PUNCT iajs-53 226 1 sci sci PROPN iajs-53 226 2 . . PUNCT iajs-53 226 3 vol vol NOUN iajs-53 226 4 . . PROPN iajs-53 226 5 29 29 NUM iajs-53 226 6 ( ( PUNCT iajs-53 226 7 1 1 NUM iajs-53 226 8 ) ) PUNCT iajs-53 226 9 2016 2016 NUM iajs-53 226 10 في في SCONJ iajs-53 226 11 امصال امصال PROPN iajs-53 226 12 1 1 NUM iajs-53 226 13 - - PUNCT iajs-53 226 14 النمو النمو NOUN iajs-53 226 15 شبيه شبيه PROPN iajs-53 226 16 االنسولين االنسولين PROPN iajs-53 226 17 لعاملدراسة لعاملدراسة PROPN iajs-53 226 18 مقارنة مقارنة PROPN iajs-53 226 19 المتغيرات المتغيرات PROPN iajs-53 226 20 الكيموحيوية الكيموحيوية PROPN iajs-53 226 21 المسيطرين المسيطرين PROPN iajs-53 226 22 وغير وغير PROPN iajs-53 226 23 المسيطرين المسيطرين VERB iajs-53 226 24 على على PROPN iajs-53 226 25 الدهون الدهون NOUN iajs-53 226 26 في في ADP iajs-53 226 27 مرضى مرضى PROPN iajs-53 226 28 النوع النوع PROPN iajs-53 226 29 الثاني الثاني PROPN iajs-53 226 30 للسكري للسكري INTJ iajs-53 226 31 .العراقيين .العراقيين NUM iajs-53 226 32 مع مع PROPN iajs-53 226 33 االصحاء االصحاء PROPN iajs-53 226 34 خيري خيري VERB iajs-53 226 35 محمودعمر محمودعمر NOUN iajs-53 226 36 الهام الهام VERB iajs-53 226 37 محمد محمد ADJ iajs-53 226 38 حسين حسين X iajs-53 226 39 جامعة جامعة NOUN iajs-53 226 40 بغداد/ بغداد/ NUM iajs-53 226 41 ) ) PUNCT iajs-53 226 42 الهيثمابن الهيثمابن PROPN iajs-53 226 43 ( ( PUNCT iajs-53 226 44 كلية كلية NOUN iajs-53 226 45 التربية التربية NOUN iajs-53 226 46 للعلوم للعلوم NOUN iajs-53 226 47 الصرفة الصرفة NOUN iajs-53 226 48 قسم قسم VERB iajs-53 226 49 الكيمياء/ الكيمياء/ NUM iajs-53 226 50 2015حزيران//30قبل 2015حزيران//30قبل NUM iajs-53 226 51 في في NOUN iajs-53 226 52 : : PUNCT iajs-53 226 53 ، ، NOUN iajs-53 226 54 2015حزيران//1استلم 2015حزيران//1استلم NUM iajs-53 226 55 في في NOUN iajs-53 226 56 : : PUNCT iajs-53 226 57 الخالصة الخالصة PROPN iajs-53 226 58 امصال امصال PROPN iajs-53 226 59 مرضى مرضى PROPN iajs-53 226 60 مرض مرض PROPN iajs-53 226 61 على على PROPN iajs-53 226 62 صورة صورة PROPN iajs-53 226 63 الدهون الدهون NOUN iajs-53 226 64 في في ADP iajs-53 226 65 1 1 NUM iajs-53 226 66 - - PUNCT iajs-53 226 67 النمو النمو NOUN iajs-53 226 68 شبيه شبيه PROPN iajs-53 226 69 االنسولين االنسولين PROPN iajs-53 226 70 عاملتهدف عاملتهدف PROPN iajs-53 226 71 الدراسة الدراسة X iajs-53 226 72 الحالية الحالية ADP iajs-53 226 73 الى الى PROPN iajs-53 226 74 مقارنة مقارنة PROPN iajs-53 226 75 تاثير تاثير NOUN iajs-53 226 76 .السكري .السكري VERB iajs-53 226 77 المسيطرين المسيطرين ADJ iajs-53 226 78 وغير وغير ADV iajs-53 226 79 المسيطرين المسيطرين VERB iajs-53 226 80 على على PROPN iajs-53 226 81 ارتفاع ارتفاع PROPN iajs-53 226 82 الدهون الدهون PROPN iajs-53 226 83 بالدم بالدم PROPN iajs-53 226 84 الذين الذين PROPN iajs-53 226 85 لهم لهم PROPN iajs-53 226 86 المعالجة المعالجة PROPN iajs-53 226 87 الطبية الطبية NOUN iajs-53 226 88 نفسها نفسها ADV iajs-53 226 89 ومقارنتهم ومقارنتهم VERB iajs-53 226 90 مع مع PRON iajs-53 226 91 االصحاء االصحاء NOUN iajs-53 226 92 , , PUNCT iajs-53 226 93 عامل عامل NOUN iajs-53 226 94 المتغيرات المتغيرات PROPN iajs-53 226 95 الكيموحيوية الكيموحيوية PROPN iajs-53 226 96 التي التي PROPN iajs-53 226 97 تم تم PROPN iajs-53 226 98 قياسها قياسها PROPN iajs-53 226 99 , , PUNCT iajs-53 226 100 سكر سكر AUX iajs-53 226 101 الدم الدم PROPN iajs-53 226 102 الصيامي الصيامي PROPN iajs-53 226 103 , , PUNCT iajs-53 226 104 الهيموكلوبين الهيموكلوبين NOUN iajs-53 226 105 المسكر المسكر NOUN iajs-53 226 106 , , PUNCT iajs-53 226 107 االنسولين االنسولين PROPN iajs-53 226 108 الصيامي الصيامي VERB iajs-53 226 109 وتضمنت وتضمنت PROPN iajs-53 226 110 , , PUNCT iajs-53 226 111 صورة صورة PROPN iajs-53 226 112 الدهون الدهون X iajs-53 226 113 ( ( PUNCT iajs-53 226 114 الكولسترول الكولسترول PROPN iajs-53 226 115 الكلي الكلي PROPN iajs-53 226 116 , , PUNCT iajs-53 226 117 الدهون الدهون NOUN iajs-53 226 118 الثالثية الثالثية ADJ iajs-53 226 119 , , PUNCT iajs-53 226 120 الاليبوبروتينات الاليبوبروتينات VERB iajs-53 226 121 عالية عالية PROPN iajs-53 226 122 الكثافة الكثافة PROPN iajs-53 226 123 , , PUNCT iajs-53 226 124 الاليبوبروتينات الاليبوبروتينات VERB iajs-53 226 125 1 1 NUM iajs-53 226 126 - - PUNCT iajs-53 226 127 النمو النمو NOUN iajs-53 226 128 شبيه شبيه PROPN iajs-53 226 129 االنسولين االنسولين PROPN iajs-53 226 130 مقاومة مقاومة NOUN iajs-53 226 131 االنسولين االنسولين NOUN iajs-53 226 132 . . PUNCT iajs-53 227 1 كشفت كشفت PROPN iajs-53 227 2 النتائج النتائج PROPN iajs-53 227 3 عن عن PROPN iajs-53 227 4 زيادة زيادة NOUN iajs-53 228 1 , , PUNCT iajs-53 228 2 واطئة واطئة PROPN iajs-53 228 3 الكثافة الكثافة PROPN iajs-53 228 4 , , PUNCT iajs-53 228 5 الاليبوبروتينات الاليبوبروتينات VERB iajs-53 228 6 واطئة واطئة PROPN iajs-53 228 7 الكثافة الكثافة PROPN iajs-53 228 8 جدا جدا PROPN iajs-53 228 9 ) ) PUNCT iajs-53 228 10 , , PUNCT iajs-53 228 11 ومؤشر ومؤشر VERB iajs-53 228 12 البالزما البالزما NOUN iajs-53 228 13 المعصد المعصد PROPN iajs-53 228 14 , , PUNCT iajs-53 228 15 الاليبوبروتينات الاليبوبروتينات VERB iajs-53 228 16 واطئة واطئة PROPN iajs-53 228 17 الكثافة الكثافة PROPN iajs-53 228 18 , , PUNCT iajs-53 228 19 الدهون الدهون NOUN iajs-53 228 20 الثالثيةالكلي الثالثيةالكلي NOUN iajs-53 228 21 , , PUNCT iajs-53 228 22 الكولسترول الكولسترول PROPN iajs-53 228 23 معنوية معنوية NOUN iajs-53 228 24 في في X iajs-53 228 25 ( ( PUNCT iajs-53 228 26 السكر السكر NOUN iajs-53 228 27 الصيامي الصيامي PROPN iajs-53 228 28 , , PUNCT iajs-53 228 29 الهيموغلوبين الهيموغلوبين PROPN iajs-53 228 30 المسكر المسكر NOUN iajs-53 228 31 نقصان نقصان PROPN iajs-53 228 32 لوحظ لوحظ ADJ iajs-53 228 33 بينما بينما NOUN iajs-53 228 34 , , PUNCT iajs-53 228 35 ) ) PUNCT iajs-53 228 36 homa homa NOUN iajs-53 228 37 - - PUNCT iajs-53 228 38 irو irو NOUN iajs-53 228 39 , , PUNCT iajs-53 228 40 الاليبوبروتينات الاليبوبروتينات VERB iajs-53 228 41 واطئة واطئة PROPN iajs-53 228 42 الكثافه الكثافه PROPN iajs-53 228 43 جدا جدا PROPN iajs-53 228 44 , , PUNCT iajs-53 228 45 مؤشر مؤشر NOUN iajs-53 228 46 البالزما البالزما NOUN iajs-53 228 47 المعصد المعصد NOUN iajs-53 228 48 , , PUNCT iajs-53 228 49 مستوى مستوى PROPN iajs-53 228 50 االنسولين االنسولين PROPN iajs-53 228 51 مقارنة مقارنة NOUN iajs-53 228 52 مع مع NOUN iajs-53 228 53 المجموعة المجموعة ADJ iajs-53 228 54 3 3 NUM iajs-53 228 55 والمجموعة والمجموعة NOUN iajs-53 228 56 2المجموعة 2المجموعة NUM iajs-53 228 57 والكوليسترول والكوليسترول NOUN iajs-53 228 58 عالي عالي NOUN iajs-53 228 59 الكثافة الكثافة NOUN iajs-53 228 60 في في SCONJ iajs-53 228 61 1 1 NUM iajs-53 228 62 - - PUNCT iajs-53 228 63 النمو النمو NOUN iajs-53 228 64 شبيه شبيه PROPN iajs-53 228 65 االنسولين االنسولين NOUN iajs-53 228 66 عاملمعنوي عاملمعنوي NOUN iajs-53 228 67 في في PRON iajs-53 228 68 مع مع PROPN iajs-53 228 69 المجموعتين المجموعتين VERB iajs-53 228 70 بالمقارنةفي بالمقارنةفي VERB iajs-53 228 71 1 1 NUM iajs-53 228 72 - - PUNCT iajs-53 228 73 انخفاض انخفاض NOUN iajs-53 228 74 عامل عامل NOUN iajs-53 228 75 النمو النمو PROPN iajs-53 228 76 شبيه شبيه PROPN iajs-53 228 77 االنسولين االنسولين PROPN iajs-53 228 78 الدراسة الدراسة PROPN iajs-53 228 79 انالمحصلة انالمحصلة PROPN iajs-53 229 1 التي التي PROPN iajs-53 229 2 استنتجت استنتجت PROPN iajs-53 229 3 من من PRON iajs-53 229 4 هذه هذه PROPN iajs-53 229 5 .1 .1 NUM iajs-53 229 6 مجموعة مجموعة PROPN iajs-53 229 7 االصحاء االصحاء PROPN iajs-53 229 8 التي التي PROPN iajs-53 229 9 قد قد PROPN iajs-53 229 10 تؤدي تؤدي ADJ iajs-53 229 11 الى الى VERB iajs-53 229 12 مستويات مستويات PROPN iajs-53 229 13 عالية عالية NOUN iajs-53 229 14 من من DET iajs-53 229 15 مقاومة مقاومة NOUN iajs-53 229 16 االنسولين االنسولين NOUN iajs-53 229 17 بينما بينما VERB iajs-53 229 18 اليوجد اليوجد PROPN iajs-53 229 19 تاثير تاثير PROPN iajs-53 229 20 الرتفاع الرتفاع PROPN iajs-53 229 21 دهون دهون NOUN iajs-53 229 22 في في SCONJ iajs-53 229 23 الدم الدم NOUN iajs-53 229 24 على على NOUN iajs-53 229 25 . . PUNCT iajs-53 230 1 1 1 NUM iajs-53 230 2 - - PUNCT iajs-53 230 3 نسولينعامل نسولينعامل NOUN iajs-53 230 4 النمو النمو NOUN iajs-53 230 5 شبيه شبيه PROPN iajs-53 230 6 اال اال NOUN iajs-53 230 7 .مقاومة .مقاومة X iajs-53 230 8 النسولين النسولين VERB iajs-53 230 9 ، ، X iajs-53 230 10 1 1 NUM iajs-53 230 11 - - PUNCT iajs-53 230 12 النمو النمو NOUN iajs-53 230 13 شبيه شبيه ADJ iajs-53 230 14 االنسولين االنسولين ADJ iajs-53 230 15 عامل عامل NOUN iajs-53 230 16 الثاني،داء الثاني،داء PROPN iajs-53 230 17 السكري السكري ADJ iajs-53 230 18 النوع النوع NOUN iajs-53 230 19 : : PUNCT iajs-53 230 20 المفتاحيةالكلمات المفتاحيةالكلمات VERB